+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 34145

Chapter 34145 contains a list of PDF Full Texts available from EurekaMag.

Marotta, F.; Chui, D.H.; Fesce, E.; Zhong, G.G.; Ideo, G., 1991:
Urogastrone induced duodenal bicarbonate secretion in rats is partially mediated by prostaglandin synthesis

Chui, D.H.; Marotta, F.; Safran, P.; Fesce, E.; Ideo, G., 1991:
Urogastrone protects from stress induced impairment of gastric alkaline secretion in rats

Gonzales, E.T.Jr, 1991:
Urogenital abnormalities

Ulmsten, U., 1994:
Urogenital ageing

Goran, Samsioe, 1997:
Urogenital ageing A hidden problem

Bachmann, G., 1995:
Urogenital ageing: an old problem newly recognized

Barlow, David, H., 1995:
Urogenital ageing Introduction

Ulmsten, Ulf, 1993:
Urogenital ageing and estrogen deficiency Effects on actual tissues

Szendei Gyorgy, Gyorgy Papp, 1993:
Urogenital alterations during the climacterium

Schlegel, P.N.; Shin, D.; Goldstein, M., 1995:
Urogenital anomalies in men with congenital absence of the vas deferens

Bachmann, G.; Cardozo, L.; Mcclish, D.; Fonda, D., 1997:
Urogenital atrophy Need for standardized assessment of outcomes A rut committee report

Campos, J.A.; Cota, A.; Sanchez, C., 1997:
Urogenital diaphragm raising maneuver The Gil-Vernet technique

Ohtomo, Hiroshi, 1996:
Urogenital diseases by parasites

Mertl, P.; Diarra, B.; Belicar, M.; Stoppa, R.; Laude, M., 1996:
Urogenital fascia Anatomical basis and surgical applications

Furr, P.M.; Taylor Robinson, D., 1996:
Urogenital infections in rodents

Huong, D.L.; Papo, T.; Piette, J.C.; Wechsler, B.; Bletry, O.; Richard, F.; Valcke, J.C.; Godeau, P., 1995:
Urogenital manifestations of Wegener granulomatosis

Harris, H.T., 1996:
Urogenital muscle exercise sensor system

Harris, H.T., 1998:
Urogenital muscle exerciser

Copin, E.; Lebrun, L., 1991:
Urogenital mycoplasma infections

Tuttle, D.; Piper, J., 1995 :
Urogenital mycoplasma pneumonitis among premature infants, a unique clinical syndrome with suboptimal outcome

Mazzoli, S.; Spina, C.; Balocchini, E.; Blanc, P.L.; Cruciani, G.; Marino, N.; Mecocci, L.; Tatini, S.; Vichi, F.; E.A., 1992:
Urogenital mycoplasmata and hiv related strains mycoplasma fermentans incognitus strain in hiv seropositive patients

Cecio, A.; Vittoria, A., 1989:
Urogenital paraneurons in several mammals

Kaplan, S.A.; Blaivas, J.G.; Breuer, A., 1994:
Urogenital physiology

Bojrab, M.J., 1989:
Urogenital problems things important for a technician to know

Chiba, T.; Aruga, S.; Usami, T.; Ohta, N., 1994:
Urogenital sinus cyst A case report

Mayersak, J.S.; Viviano, C.J.; Babiarz, J.W., 1996:
Urogenital sinus-ejaculatory duct cyst: a case report with pre-operative magnetic resonance and computed axial tomography imaging

Price, J.; Yursis, D.; Bustos, S.; Finnerty, C.; Hahn, J., 1998:
Urogenital swab processing protocol for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compatible with a fluorescent energy transfer detection system using strand displacement amplification

Van, D.W.iler, P.H.M.; Van Geelen, J.M.; Arnolds, H.T.H., 1997:
Urogenital symptoms and resulting discomfort in non-institutionalized Dutch women aged 50 to 75 years

Kreder, K.J.; Webster, G.D., 1993:
Urogenital trauma associated with pelvic fractures and their management

Kokuho, M.; Mashiko, K., 1995:
Urogenital trauma in Advanced Life Saving Emergency Service Center of Nippon Medical School

Verdon, M.; Siegel, N.; Jenny, C.; Springwater, R.; Critchlow, C.W.; Holmes, K.K., 1993:
Urogenital trichomoniasis in men

Benchekroun, T.S.; Belkacem, R.; Jorio, M.; E.H.rim, L.; Outarahout, O.; E.M.lki Tazi, A., 1996:
Urogenital tuberculosis in children

Swanson, D.P.; Weingarden, M., 1990:
Urographic contrast media excretory and retrograde

Katzberg, R.W., 1997:
Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity

Freeman, R.H.; Forte, L.R.; Hamra, F.K.; Currie, M.G.; Krause, W.J., 1994:
Uroguanylin A potential natriuretic peptide hormone produced by the intestine

Forte, L.R.; Hamra, F.K.; Fan, X.H.; Krause, W.J.; Currie, M.G.; Freeman, R.H., 1994:
Uroguanylin An intestinal peptide hormone with natriuretic activity

Kinoshita, H.; Fujimoto, S.; Yokota, N.; Date, Y.; Nakazato, M.; Eto, T., 1997:
Uroguanylin acts as a natriuretic factor via guanylate cyclase C

Nakazato, M., 1998:
Uroguanylin acts as a natriuretic factor via guanylyl cyclase C

Prinz, C.; Neumayer, N.; Classen, M.; Adermann, K.; Forssmann, W.G.; Schepp, W., 1997:
Uroguanylin receptors on rat gastric enterochromaffin-like cells

Joo, N.S.; Kim, H.D.; Forte, L.R.; Clarke, L.L., 1997:
Uroguanylin regulation of anion secretion in mouse intestine

Moss, N.G.; Fellner, R.C.; Qian, X.; Yu, S.J.; Li, Z.; Nakazato, M.; Goy, M.F., 2008:
Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide

Summitt, R.L., 1993:
Urogynecologic causes of chronic pelvic pain

Mcintosh, L.J.; Richardson, D.A., 1993:
Urogynecologic infections

Builov, V.M.; Danilov, O.A., 1991:
Urointestinal fistula after sigmoid colon perforation

Kanse, S.M.; Chavakist, T.; Lupu, F.; Preissner, K.T., 1998:
Urokinase -mediated proteolytic and mitogenic functions in the vasculature New facets of uPA-receptor-dependent and -independent activities

Murakami, T.; Kawakami, H., 1990:
Urokinase, a scavenger of affected tubules in acute worsening during macroscopic hematuria of IgA nephropathy?

Christow, S.; Bychkov, R.; Schroder, C.; Gulba, D.; Haller, H.; Dumler, I., 1998:
Urokinase activates calcium-dependent potassium channels in U937 cells via a release of calcium from internal stores

Kanalas, John, J., 1992:
Urokinase activation of plasminogen bound to the Heymann nephritis autoantigen

Varma, V.K.; Parks, J.M.; Li, X.N.ng; Koons, J.C.; Grammer, J.R.; Booyse, F.M., 1993:
Urokinase activation of surface-localized endothelial cell fibrinolysis is regulated by thrombin

Yan, L.; Mcguire, M.H.; Yee, J.A., 1994:
Urokinase activity and invasion of matrigel by invasive and noninvasive variants of the OSPR human osteosarcoma cell line

Mcguire, P.G., 1990:
Urokinase activity in the developing avian heart

Jaenicke, F.; Thomssen, C.; Pache, L.; Schmitt, M.; Graeff, H., 1994:
Urokinase and PAI-1 as selection criteria for adjuvant chemotherapy in axillary node-negative breast cancer patients

Kuhn, W.; Pache, L.; Schmalfeldt, B.; Dettmar, P.; Schmitt, M.; Jaenicke, F.; Graeff, H., 1994:
Urokinase and PAI-1 predict survival in advanced ovarian cancer patients after radical surgery and platinum-based chemotherapy

Webber, M.M.; Waghray, A.; Rhim, J.S.; Deocampo, N.D., 1995:
Urokinase and gelatinases in the proteolytic cascade in human prostate cancer invasion Implication in cancer prevention

Jaenicke, F.; Thomssen, C.; Prechtl, A.; Schmitt, M.; Graeff, H., 1994:
Urokinase and its inhibitor PAI-1 as selection criteria for adjuvant chemotherapy in node negative breast cancer

Pache, L.; Jaenicke, F.; Schmitt, M.; Graeff, H., 1994:
Urokinase and its inhibitor PAI-1 in breast cancer What mode of extraction should be used?

Pache, L.; Jaenicke, F.; Schmitt, M.; Graeff, H., 1993:
Urokinase and its inhibitor PAI-I in breast cancer What mode of extraction should be used?

Zhang, G.; Eddy, A.A., 2008:
Urokinase and its receptors in chronic kidney disease

Adida, C.; Xu, Y.; Peraldi, M.N.elle; Hagege, J.; Rondeau, E., 1993:
Urokinase and its type 1 inhibitor in normal human kidney and in renal carcinoma

Keller, M.P.; Hoch, J.R.; Silver, D., 1991:
Urokinase and mannitol modification of skeletal muscle ischemia reperfusion injury

Das, A.; Mclamore, A.; Mcguire, P.G., 1998:
Urokinase and metalloproteinase activity is increased in retinas in a mouse model of retinal neovascularization

Gleeson, N.; Gonsalves, R.; Bonnar, J., 1992:
Urokinase and plasminogen activator inhibitor type 2 in endometrial cancer

Goltzman, D.; Bolivar, I.; Moroz, L.A.; Rabbani, S.A., 1992:
Urokinase and the mechanism of osteoblastic metastases by prostate cancer

Waltz, D.A.; Sailor, L.Z.; Chapman, H.A.Jr, 1992:
Urokinase and urokinase inhibitors regulate the differentiation response of myeloid cells to cytokines

Blasi, F., 1993:
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

Del Vecchio, S.; Stoppelli, P.; Fonti, R.; Carriero, M.V.; Yong; L.P.e; Salvatore, M., 1993:
Urokinase and urokinase receptor overexpression in breast carcinoma as compared to benign lesions

Chapman, H.A.Jr; Nusrat, A.R., 1991:
Urokinase and urokinase receptors and inhibitors in the ontogeny of mononuclear phagocytes

Pena, E.; A Villaverde, C.; Insa, R.; Salvat, N.; Legarre, T., 1997 :
Urokinase and wound healing

Rabbani, Shafaat Ahmed, 1996:
Urokinase as a mediator of osteoblastic skeletal metastasis

Takahama, T.; Kanai, F.; Ohnishi, K.; Hiraishi, M.; Yamazaki, Z.; Naruse, Y.; Furuse, A.; Yoshitake, T., 1992:
Urokinase as an anticoagulant for left ventricular assist device lvad

Takahashi, K.; Masumura, S., 1989:
Urokinase at the focal adhesion contacts of a metastatic tumor cell may modulate local proteolytic action via the receptor

Handley, M.A.; Steigbigel, R.T.; Morrison, S.A., 1994:
Urokinase cleaves gp120 of HIV-1 and promotes viral infectivity

Hong, S.Y.; Yang, D.H.; Kim, P.N., 1991:
Urokinase concentration in the renal artery and renal vein

Maksimenko, Alexander, V., 1996:
Urokinase conjugation with fibrinogen for effective treatment of thrombosis

Masri, M.T.; Wahl, D.; Oegema, T.; Luikart, S., 1997:
Urokinase degrades alpha-actinin to produce a 31 kD fragment with monocyte/macrophage differentiating activity

Lotti, T.; Teofoli, P.; Senesi, C.; Fedi, A.M.; Bonan, P.; Panconesi, E., 1989:
Urokinase dependent peribulbar proteolysis is increased in alopecia areata aa

Zhao, Y.; Lyons, C.E.; Xiao, A.; Templeton, D.J.; Sang, Q.Amy.; Brew, K.; Hussaini, I.M., 2008:
Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion

Wolfe, J.H.; Murali, R.; Murali, M.R.; Chice, S.M.; Durkin, H.G.; Auci, D.L., 1995:
Urokinase dysregulation and progression of HIV infection into full blown AIDS in children

Epidermidis, S.; Gagnon, R.F.; Richards, G.K.; Morcos, R., 1995:
Urokinase enhancement of rifampin activity against experimental biofilms in spent PD fluid

Krisinski Majka, S.; Mcguire, P., 1996:
Urokinase expression in endocardial cushion tissue mesenchymal cells is regulated in part by the ETS-2 protein

Townsend, L.E.; Trevor, K.T.; Seymour, M.S.; Ward, S.G.; Reitz Vick, D.; Ellmers, B.; Glover, J.G., 1995:
Urokinase expression in transduced vascular endothelial cells

Selçuklu, A.; Pasaoglu, A.; Akdemir, H.; Kurtsoy, A.; Patiroglu, T.E., 1993:
Urokinase for control of scar formation after laminectomy

Hedican, S.P.; Nelson, J.B.; Bartkowski, L.M.; Simons, J.W., 1996:
Urokinase gene expression as a biomarker of invasive human prostate cancer and target for therapy

Gross, T.J.; Powers, L.S.; Davidson, B.L.; Hunninghake, G.W., 1996:
Urokinase gene transfer increases pleural fibrinolytic activity

Nusrat, R.; Taylor, L.; Hartwig, J., 1993:
Urokinase growth factor domain promotes platelet actin assembly

Daley, W.L.; Sharma, G.V.R.K., 1997:
Urokinase improves endothelium-dependent relaxation in experimental pulmonary embolism

Salvat, N.; A Villaverde, C.; Pena, E.; Juan, O.; Tibau, N.; Torello, L., 1997 :
Urokinase in the metabolism of the vascular wall

Jones, G.R.; Konsler, G.K.; Dunaway, R.P., 1994:
Urokinase in the treatment of catheter related sepsis

Schiza, S.; Bouros, D.; Panagou, P.; Drositis, J.; Tzanakis, N.; Siafakas, N.M., 1995:
Urokinase in the treatment of complicated parapneumonic effusions and empyema

Marian, B.; Harvey, S.; Infante, D.; Markus, G.; Winawer, S.; Friedman, E., 1990:
Urokinase induction by endogenous tumor promoters in human colon carcinomas

Waltz, D.; Sailor, L.; Chapman, H., 1992:
Urokinase inhibitors regulate cytokine induced myeloid cell differentiation

Liu, J.N.; Lecontel, C.; Zhang, D.Z.; Chen, Y.H.; Gurewich, V.; Chermann, J.C., 1996:
Urokinase inhibits infectivity by common North American Strains of HIV-1

Oh, D.; Kwaan, H.C.; Goolsby, C.; Verrusio, E.; Yoshida, E., 1993:
Urokinase is mitogenic on tumor cells in culture

Kwaan, H.C.; Oh, D.Y.; Goolsby, C.; Verrusio, E.; Yoshida, E., 1994:
Urokinase is mitogenic to tumor cells in culture

Gyetko, M.R.; Chen, G.H.; Mcdonald, R.; Goodman, R.; Huffnagle, G.; Wilkinson, C.C.; Fuller, J.A.; Toews, G.B., 1995:
Urokinase is required for the pulmonary inflammatory response to C neoformans

Ghosh, S.; Yan, L.; Mcguire, M.H.; Patterson, E.B.; Yee, J.A., 1996:
Urokinase levels and matrix degradation in invasive and non-invasive variants of an osteosarcoma cell line

Berman, M.; Hayashi, K.; Young, E.; Pease, S.; Smith, D.; E.G.atit A.; Askew, M.; Cragoe, E.J.Jr, 1989:
Urokinase like plasminogen activator corneal epithelial migration and defect formation

Juul, S.E.; Nick, H.S.; Visner, G.A., 1997:
Urokinase mRNA is induced by hyperoxia in mouse macrophages

Quax, P.H.A.; Van Muijen, G.N.P.; Weening Verhoeff, E.J.D.; Verheijen, J.H., 1990:
Urokinase mediated degradation of extracellular matrix in vitro correlates with formation of lung metastasis in nude mice

Ronday, H.K.; Smits, H.H.; Quax, P.H.A.; Van Der Pluijm, G.; Lowik, C.W.G.M.; Breedveld, F.C.; Verheijen, J.H., 1995:
Urokinase mediated, plasmin dependent degradation of bone-like matrix

O.M.C.; Bass, L.S.; Chuck, R.S.; Johnson, J.P.; Parengi, S.; Treat, M.R.; Nowygrod, R., 1990:
Urokinase modulation of weld strength in laser anastomoses

Stepanova, I.; Stepanova, V.; Zamalevskaya, S.; Goncharova, E.; Bebelashvili, R.; Domogatsky, S.; Tkachuk, V., 1997:
Urokinase mutant form could regulate vascular remodelling following cardiovascular surgery

Carroll, S.M.; Knoepfler, P.S.; Bloor, C.M., 1993:
Urokinase plasminogen activator activity is increased during collateral development in a porcine model of gradual coronary artery occlusion

Brown, P.A.J.; Wilson, H.M.; Morrison, L.; Booth, N.A.; Haites, N.E.; Power, D.A.; Simpson, J.G., 1993:
Urokinase plasminogen activator and its inhibitor in cultured whole glomeruli and glomerular cell cultures

Fredstorp, M.; Langstrom, E.; Brunner, N.; Koul, A.; Hogberg, T.; Ferno, M., 1997:
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic factors in uterine malignancies A pilot study

Zekanowska, E.; Kotschy, M.; Cieslinski, K.; Michalski, A.; Pawlak, W.; Lambrecht, W., 1998:
Urokinase plasminogen activator and its inhibitors in tissue extracts of planoepithelial lung cancer

Gutova, M.; Najbauer, J.; Frank, R.T.; Kendall, S.Edward.; Gevorgyan, A.; Metz, M.Z.; Guevorkian, M.; Edmiston, M.; Zhao, D.; Glackin, C.A.; Kim, S.U.; Aboody, K.S., 2008:
Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors

Pels, K.; Labinaz, M.; Garvin, M.R.; Hoffert, C.; O'brien, E.R., 1997:
Urokinase plasminogen activator expression after balloon injury is associated with adventitial cell migration and angiogenesis of the vasa vasorum

Padro, T.; Steins, M.; Li, C.X.; Kienast, J., 1996:
Urokinase plasminogen activator in human atherosclerotic coronary arteries

Casslen, B.; Liu, C.L.; Martinsson, G.; Hansson, S.; Lecander, I.; Astedt, B., 1996:
Urokinase plasminogen activator in serous ovarian tumors Translocation of mRNA expression from the epithelium in benign and well differentiated to the stroma in poorly differentiated tumors

Nykjaer, A.; Jensen, P.H.; Petersen, C.M.; Moller, B.; Moestrup, S.K.; Holtet, T.L.; Etzerodt, M.; Thogersen, H.C.; Munch, M.; E.A., 1992:
Urokinase plasminogen activator inhibitor type 1 complex binds to the purified alpha a macroglobulin receptor

Hofmann, R.; Kruesmann, J.; Lehmer, A.; Hartung, R., 1997:
Urokinase plasminogen activator is an independent prognostic factor for muscle invasive bladder cancer

Ritmeester, A.R.; Coffman, K.T.; Wang, J.; Henkin, J.; Waters, D.J., 1998:
Urokinase plasminogen activator is differentially expressed by canine prostate cancer cells

Jensen, P.J.; Carmeliet, P.; Collen, D.; Lavker, R.M., 1998:
Urokinase plasminogen activator promotes keratinocyte proliferation in vivo

Fuhrman, B.; Khateeb, J.; Shiner, M.; Nitzan, O.; Karry, R.; Volkova, N.; Aviram, M., 2008:
Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism

Hartmann, J.R., 1996:
Urokinase recanalization of chronically occluded aortocoronary vein grafts

Verspaget, H.W.; Sier, C.F.M.; Ganesh, S.; Vloedgraven, H.J.M.; Heerding, M.M.; Griffioen, G.; Van Hogezand, R.A.; Lamers, C.B.H.W., 1996:
Urokinase receptor and plasminogen activator inhibitors in tissue of patients with inflammatory bowel disease

Bohuslav, J.; Horejsi, V.; Majdic, O.; Weidle, U.; Knapp, W.; Stockinger, H., 1994:
Urokinase receptor and protein kinases containing domains on monocytes

Jadi, M.; Lopez Pedrera, C.; Malagon, M.M.; Ingles Esteve, J.; Dorado, G.; Torres, A.; Velasco, F.; Felez, J., 1996:
Urokinase receptor and tissue factor in bleeding complications of leukemic patients

Liang, M.; Wang, Y.; Doe, W.F., 1994:
Urokinase receptor are essential to plasminogen dependent tissue invasion by colon cancer cells

Bohuslav, J.; Horejsi, V.; Hansmann, C.; Stoeckl, J.; Wiedle, U.H.; Majdic, O.; Bartke, I.; Knapp, W.; Stokinger, H., 1995:
Urokinase receptor complexed to beta-2-integrins and SRC-kinases in human monocytes

Rabbani, S.A., 1997:
Urokinase receptor directed immunodiagnostic and immunotherapeutic strategies for prostate and breast cancer

Jardi, M.; Ingles Esteve, J.; Fabregas, P.; Azqueta, C.; Felez, J., 1993:
Urokinase receptor expression among peripheral blood cells and leukemic cell lines

Jardi, M.; Ingles Esteve, J.; Fabregas, P.; Azqueta, C.; Velasco, F.; Felez, J., 1994:
Urokinase receptor expression during hematopoietic maturation

Krasnikova, T.; Prfyonova, Y.; Arefieva, T.; Alekseeva, I.; Mukhina, S.; Dobrovolsky, A.; Titaeva, Y.; Lyakishev, A., 1997:
Urokinase receptor expression on monocytes and plasma urokinase content are decreased in coronary artery disease

Dumler, I.; Weis, A.; Maasch, C.; Gulba, D.; Haller, H., 1997:
Urokinase receptor induces the JAK/STAT pathway in endothelial cells

Rosenberg, S.; Spear, K.L.; Martin, E.J., 1998:
Urokinase receptor ligands

Rao, N.K.; Xu, H.; Wei, Y.; Chapman, H.A.; Simon, D.I., 1995:
Urokinase receptor occupancy modulates Mac-1 -mediated fibrinogen degradation by human monocytes

Arefieva, T.; Volynskaya, E.; Baidun, L., 1998:
Urokinase receptor/urokinase system in U937 cells and mature monocytes

Daley, L.; Deitcher, S.R.; Bojar, R.M.; Pandian, N.G., 1994:
Urokinase resolution of impending paradoxic embolus in transit: evaluation by multiplane transesophageal echocardiography

Suarez, C.R.; Ow, E.P.; Lambert, G.H.; Anderson, C.L.; Purewal, N.S., 1989:
Urokinase therapy for a central venous catheter thrombus

Emery, E.; Redondo, A.; Berthelot, J.L.; Ouhes, I.B.uali O.; Rey, A., 1998:
Urokinase therapy in massive intraventricular hemorrhage Report of a case in pregnant woman, with a review of the literature

Roller, M.; Perry, C.; Sutton, J.M.; Grambow, D.; Kandalwal, M.; Palacios, I.; Rosenschein, U., 1993:
Urokinase therapy in the catheterization laboratory is associated with high rate of bleeding

Smith, P.K.; Miller, D.A.; Lail, S.; Mehta, A.V., 1991:
Urokinase treatment of neonatal aortoiliac thrombosis caused by umbilical artery catheterization: a case report

Pereyra Alfonso, S.; Bal, D.K.er Joffe, E., 1990:
Urokinase type plasminogen activator activity during tumor growth

Reilly, D.; Andreasen, P.; Duffy, M.J., 1989:
Urokinase type plasminogen activator and its inhibitor pai 1 in human breast cancer

Bialkowska, A.; Kotschy, M.; Michalski, A.; Betlejewski, S.; Burduk, D.; Zekanowska, E., 1998:
Urokinase type plasminogen activator and its inhibitors in extracts of planoepithelial larynx cancer

Berdel, W.E.; Steinhauser, G.; Schmitt, M.; Graeff, H., 1991:
Urokinase type plasminogen activator can modulate clonal growth of hl 60 leukemic cells in vitro

Gross, T.J.; Simon, R.H.; Sitrin, R.G., 1990:
Urokinase type plasminogen activator expression by rat pulmonary alveolar epithelial cells

Von Der Ahe, D.; Pearson, D.; Mueller Berghaus, G.; Nagamine, Y., 1990:
Urokinase type plasminogen activator gene expression regulation by protein kinase a and c pathways

Nagamine, Y.; Altus, M.S.; Nakagawa J I.; Pearson, D.; Von Der Ahe, D., 1991:
Urokinase type plasminogen activator gene regulation as a model system for studying transcriptional activation by the camp dependent protein kinase pathway

Von Der Ahe, D.; Nagamine, Y.; Mueller Berghaus, G., 1990:
Urokinase type plasminogen activator gene transcriptional control of plasminogen activator synthesis and regulation of expressed activity

Skelly, M.M.; Mulcahy, H.E.; Connell, T.; Troy, A.; Duggan, C.; Duffy, M.J.; Sheahan, K.; O'donoghue, D.P., 1995:
Urokinase type plasminogen activator is independently related to outcome in colorectal cancer

Sappino A P.; Huarte, J.; Belin, D.; Vassalli J D., 1989:
Urokinase type plasminogen activator messenger rna in implanting murine embryos

Botteri, F.; Van Der Putten, H.; Nagamine, Y., 1989:
Urokinase type plasminogen activator tissue specific and developmental gene regulation in transgenic mice

Philippe, J.; Offner, F.; Declerck, P.; Vogelaers, D.; Leroux Roels, G.; Baele, G., 1990:
Urokinase type plasminogen activator u pa antigen plasma levels in septic shock

Odekon, L.E.; Gilboa, N.; Del Vecchio, P.J.; Gudewicz, P.W., 1989:
Urokinase type plasminogen activator u pa released from phorbol ester treated human endothelial cells is chemotactic for human neutrophils

Quax, P.H.A.; Khouw, I.M.S.L.; Bakker, T.R.; Van Leeuwen, R.T.J.; Verheijen, J.H., 1994:
Urokinase-Type plasminogen activator is involved in smooth muscle cell migration in wounded cultures

Kerins, D.M.; Hao, Q.; Naftilan, A.J.; Vaughan, D.E., 1995:
Urokinase-induced gene expression in cultured human endothelial cells

Webber, M.M.; Waghray, A., 1994:
Urokinase-mediated extracellular matrix degradation in human prostate carcinoma and its inhibition by retinoic acid

Dear, A.E.; Medcalf, R.L., 1996:
Urokinase-mediated, AP-1 associated, induction of plasminogen activator inhibitor type-2 A novel auto-regulatory loop

Wilson, H.M.; Brown, P.A.J.; Reid, F.J.; Booth, N.A.; Simpson, J.G.; Power, D.A.; Haites, N.E., 1993:
Urokinase-plasminogen activator is synthesised in vitro by human glomerular epithelial but not mesangial cells

Zheng, Q.; Tang, Z.; Wu, Z., 1998:
Urokinase-type plasminogen activator , uPA receptor and inhibitors expression in hepatocellular carcinoma in relation to cancer invasion/metastasis and prognosis

Fazioli, F.; Blasi, F., 1994:
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

Salame, M.Y.; Martin, W.; More, R.S.; Mahadeva, H.; Samani, N.J.; Debono, D.P., 1996:
Urokinase-type plasminogen activator and its receptor are increased in the vessel wall following experimental angioplasty

Quax, P.H.A.; D.B.rt, A.C.W.; Janson, A.F.; Van Muijen, G.N.P.; Weidle, U.; Verheijen, J.H., 1994:
Urokinase-type plasminogen activator and its receptor in extracellular matrix degradation by melanoma cell lines in vitro

Nielsen, L.L.; Gurnani, M.; Meador, V.P.; Blood, C.H., 1995:
Urokinase-type plasminogen activator and its receptor in wap-ras/F, MMTV-PyV middle T, and double transgenic mice

Hagiya, Y.; Nonaka, T.; Tomioka, Y.; Fukao, H.; Okada, K.; Matsuo, O., 1992:
Urokinase-type plasminogen activator and its specific receptor in human lung adenocarcinoma

Duffy, M.J., 1993:
Urokinase-type plasminogen activator and malignancy

Miseljic, S.; Galandiuk, S.; Myers, S.D.; Wittliff, J.L., 1995:
Urokinase-type plasminogen activator and plasminogen activator inhibitor expression in colon diseases

Landau, B.; Kwaan, H.; Verrusio, E.; Engelhard, H.; Brem, S., 1993:
Urokinase-type plasminogen activator and plasminogen activator inhibitors in human brain tumors

Dooijewaard, G.; D.M.at, M.P.M.; Meijer, P.; Kluft, C.; Binder, B.R.; Jespersen, J.; Keber, D.; Risberg, B., 1998:
Urokinase-type plasminogen activator and the risk of coronary events in patients with angina pectoris

Ferno, M.; Borg, A.; Killander, D.; Hirschberg, L.; Brundell, J., 1994:
Urokinase-type plasminogen activator as prognostic factor in breast cancer Measured with a novel immunoluminometric assays suited for routine use

Dumler, I.; Christow, S.; Weis, A.; Krentler, J.; Gulba, D., 1996:
Urokinase-type plasminogen activator associated cell proliferation

Schnaper, H.W.lliam; Mazar, A.; Barnathan, E.S.; Kleinman, H.K., 1994:
Urokinase-type plasminogen activator enhances endothelial cell differentiation through a non-proteolytic mechanism involving uPA receptor binding

Brauer, P.R.; Agrawal, M.; Hildebrandt, L.M., 1998:
Urokinase-type plasminogen activator expression during early cephalic neural crest migration

Gibbons, D.; Mulcahy, H.; Mccarthy, P.; Doyle, J.; Duffy, M.J.; Parfrey, N.A.; O'donoghue, D.P.; Sheahan, K., 1994:
Urokinase-type plasminogen activator expression in Dukes B colorectal carcinoma Correlation with multiple pathological parameters, PCNA indices and survival

Venkatesh, V.C.; Dong, W.W.D.; Mawji, N., 1998 :
Urokinase-type plasminogen activator gene expression is inhibited by glucocorticoids in human fetal lung

Padro, T.; Steins, M.; Li, C.X.; Kienast, J., 1995:
Urokinase-type plasminogen activator in human atherosclerotic lesions

Venkatesh, V.C.; Dong, W.D.; Mawji, N., 1998:
Urokinase-type plasminogen activator is inhibited by glucocorticoids in human fetal lung

Bryer, S.C.; Fantuzzi, G.; Van Rooijen, N.; Koh, T.J., 2008:
Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration

Dumler, I.; Krentler, J.; Haller, H.; Gulba, D.C., 1996:
Urokinase-type plasminogen activator receptor and Src-kinases A signal transducing complex in human smooth muscle cells

Dano, K.; Ronne, E.; Behrendt, N.; Ellis, V.; Hoyer Hansen, G.; Pyke, C.; Bruenner, N., 1996:
Urokinase-type plasminogen activator receptor antibodies

Kindzelskii, A.L.; Ahmad, I.; Anderson, D.; Zhou, M.J.; Haugland, R.P.; Mizukami, J.; Gyetko, M.; Toddi, R.F.I.; Petty, H.R., 1996:
Urokinase-type plasminogen activator receptors focus substrate proteolysis by neutrophils and tumor cells

Agrawal, M.; Brauer, P.R., 1994:
Urokinase-type plasminogen activator regulates neural crest migration in vitro

Li, C.; Jiang, Y.; Gurewich, V.; Ji, J.N., 1996:
Urokinase-type plasminogen activator stimulates its own expression in endothelial cells and monocytes

Wenninger, A.; Nekarda, H.; Schmitt, A.M.; Becker, K.; Siewert, J.R., 1994:
Urokinase-type plasminogen activator uPA and its inhibitor PAI-1 in cancer of the upper GI-tract

Kute, T.; Grondahl Hasen, J.; Russell, G.; Christensen, I.J.; Brunner, N., 1994:
Urokinase-type plasminogen activator, its inhibitor and cathepsin D predict prognosis in node negative breast cancer

Dumler, I.; Christow, S.; Weis, A.; Krentler, J.; Gulba, D.C., 1996:
Urokinase-type plasminogen activator- induced transmembrane signalling, an important contributor to human aortic smooth muscle cell growth?

Tebbe, U.; Hopkins, G.; Windeler, J.; Barth, H.; Baer, F.; Vermeer, F.; Meyer, J., 1996:
Urokinase-type plasminogen activators, latest aspects

Bugge, T.H.; Flick, M.J.; Danton, M.J.S.; Daugherty, C.C.; Romer, J.; Dano, K.; Carmeliet, P.; Collen, D.; Degen, J.L., 1996:
Urokinase-type plasminogen activatory if effective fibrin clearance in the absence of its receptor of tissue-type plasminogen activator

Dumler, I.; Krentler, J.; Haller, H.; Gulba, D.C., 1996:
Urokinase-type plasminogen activatory receptor-A potential signal-transducing molecular in atherosclerotic disease

Grondahl Hansen, J.; Brunner, N.; Clark, G.M.; Dano, K.; Hoyer Hansen, G.; Osborne, C.K.; Pedersen, H.; Rank, F.; Ronne, E., 1994:
Urokinase-type receptor in breast cancer tissue extracts Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

Sieuwerts, A.M.; Klijn, J.G.M.; Henzen Logmans, S.C.; Bouwman, I.; Van Roozendaal, K.E.P., 1998:
Urokinase-type-plasminogen-activator production by human breast fibroblasts in vitro Influence of transforming growth factor-beta1 compared with factor released by human epithelial-carcinoma cells

Albrecht, Anders, 1994:
Uroleucon pilosellae new to Finland

Horikawa, M.; Tanaka, M.; Kaku, H.; Nishii, T.; Tsunoda, T., 2008 :
Uroleuconaphins A2a, A2b, B-2a, and B-2b four yellowish pigments from the aphid Uroleucon nigtrotuberculatum Olive

Magoha, G.A.O., 1990:

Lama, G.; Marrone, N.; Spannuolo, G.; Esposito Salsano, M.; Cirillo, F.; Aulino, A.; Carbone, M.G.; Iafusco, F., 1992:
Urolithiasis Recurrence and prevention

Lallas, C.D.; Chiura, A.N.; Das, A.; Sedor, J.; Bagley, D.H., 1998:
Urolithiasis Stone location and size, and their association with microhematuria and related symptoms

Vahlensieck, W.; Hesse, A.; Nolde, A., 1993:
Urolithiasis The stone is out, what next? Principles of urinary stone metaphylaxis

Zuckerman, A.L.; Franco, I.; Kogan, S.J.; Weiss, R.A.; Roberto, L.; Palmer, L., 1992:
Urolithiasis after augmentation cystoplasty

Hayes, J.M.; Streem, S.B.; Graneto, D.; Steinmuller, D.R.; Novick, A.C., 1989:
Urolithiasis after renal transplantation

Inoguchi, M., 1993:
Urolithiasis and Chinese natural medicine

Ashturkar, R.W., 1992:
Urolithiasis and left displacement of abomasum in a bullock

Kaltenis, P.; Basys, V.; Stakisaitis, D., 1994:
Urolithiasis and unusual types of alpha-1-proteinase inhibitor

Greenstein, A.; Matzkin, H.; Braf, Z., 1990:
Urolithiasis: B. Pharmacological and instrumental treatment of stones

Ohkawa, T.; Kawamura, J., 1991:
Urolithiasis basic and clinical research

McLeod, R.S.; Churchill, D.N., 1992:
Urolithiasis complicating inflammatory bowel disease

Blacklock, N.J., 1990:
Urolithiasis epidemiology

Rahman, R.C.; Spizzirri, F.D., 1995:
Urolithiasis in Argentinian children

Kamoun, A.; Daudon, M.; Chaouachi, B.; Lakahoua, R., 1996:
Urolithiasis in Tunisian children Report of 87 cases

Jayakumar, P.M., 1993:
Urolithiasis in a buck

Shiozawa, Y.; Sakaguchi, S.; Sakakibara, O.; Yagishita, K.; Saito, M.; Yamashiro, Y., 2008:
Urolithiasis in an acute lymphoblastic leukemia child during induction chemotherapy

Silva,P.C.A.R.da; Pitombo,C.A.; Caetano,L.F.O.; Lima,A.G.; Areas,V.S.; VargasJunior,L., 2008:
Urolithiasis in an uncastrated Nelore steer

Lopez, M.M.; Castillo, L.A.; Chavez, J.B.; Ramones, C.J., 1995:
Urolithiasis in childhood Clinical presentation and metabolic study

Dumas, R., 1990:
Urolithiasis in children

Laufer, J.; Boichis, H., 1989:
Urolithiasis in children: current medical management

Palmer, L.S.; Franco, I.; Kogan, S.J.; Reda, E.; Gill, B.; Levitt, S.B., 1993:
Urolithiasis in children following augmentation cystoplasty

Ramzan, A.; Bhatti, R., 1998:
Urolithiasis in children in Pakistan

Cantani, A.; Trogolo, E.; Bussi, F.; Ruberto, U., 1989:
Urolithiasis in children state of the art

Baldree, L.A.; Pui, C.H.; Roy, S.; Noe, H.N.; Stapleton, F.B., 1990:
Urolithiasis in children with cancer a unique population

Neta,E.deS.M.; Munhoz,A.D., 2008:
Urolithiasis in dogs and cats a review

Pulz,R.S.; Silva,C.; Scott,L.A.; Simoes,C.; Santini,H.; Facin,F., 2008:
Urolithiasis in equines

Grude, Kjell, 1992:
Urolithiasis in male lambs as a flock problem when concentrates are fed

Silver, R.I.; Jeffs, R.D.; Gearhart, J.P., 1996:
Urolithiasis in the exstrophy-epispadias complex

Krmar, R.; Angelino, I.; Ferraris, J.; Ramirez, J.; Badiola, F.D.; Puigdevall, J.; Ruiz, E., 1998:
Urolithiasis in young patients after augmentation enterocystoplasty

Danso, A.P., 1991:
Urolithiasis in Zimbabwe: yesterday, today and tomorrow

Wu, W.J.; Huang, C.H.; Chiang, C.P.; Huang, C.N.; Wang, C.N., 1993:
Urolithiasis related to laxative abuse

Bhatia, V.; Halim, A., 1996:
Urolithiasis with renal insufficiency treated with extra corporeal shock wave lithotripsy

Dewys, William, D., 1991:
Urologic and male genital malignancies

Solomon, S.B.; Lee, B.R.; Bishoff, J.T.; Jackman, S.V.; Kavoussi, L.R.; Jarrett, T.W., 1998:
Urologic applications of an intraoperative real time position sensor Instrument position and orientation display on three-dimensional CT images

Portis, A.J.; Metcalfe, P.D.; Mcgann, L.E.; Chetner, M.P., 1998:
Urologic applications of iontophoresis-ex vivo analysis

Ryan, K.J.; Winfield, H.N., 1989:
Urologic applications of laparoscopic surgery

Anonymous, 1993:
Urologic applications of the Ho-YAg laser

Nath, M.; WheelerJohn, S.Jr.; Walter, J.S., 1993:
Urologic aspects of central cord syndrome

Lingeman, James, E., 1996:
Urologic aspects of nephrolithiasis management

Sotolongo, J.R., 1993:
Urologic aspects of prevention of end-stage renal disease in spinal cord injury

Heimdal, K.; Fosså, S.D., 1993:
Urologic cancer in elderly patients

Pranikoff, K., 1996:
Urologic care in long-term facilities

Pleass, H.C.; Clark, K.R.; Rigg, K.M.; Reddy, K.S.; Forsythe, J.L.; Proud, G.; Taylor, R.M., 1995:
Urologic complications after renal transplantation: a prospective randomized trial comparing different techniques of ureteric anastomosis and the use of prophylactic ureteric stents

Spitzer, D.; Staudach, A.; Joos, H.; Steiner, H., 1991:
Urologic complications in gynecologic tumor surgery

Del Pizzo, J.; Jacobs, S.C.; Sklar, G.N., 1997:
Urologic complications of bladder drained pancreatic allografts

Yang, C.C.; Assimos, D.G.; Cruz, J.M.; Savage, P.D.; Hurd, D.D.; Hart, L.J., 1992:
Urologic complications of bone marrow transplantation

Ruenes, A.; Mark, S.D.; Weinerth, J.L.; Harland, R.; Webster, G.D., 1993:
Urologic complications of simultaneous kidney-pancreas transplantation with pancreaticoduodenocystostomy

Selzman, A.A.; Hampel, N., 1993:
Urologic complications of spinal cord injury

Selzman, A.A.; Elder, J.S.; Mapstone, T.B., 1993:
Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord

Guz, B.V.; Wood, D.P.Jr; Pontes, J.E., 1989:
Urologic considerations of retroperitoneal neural sheath tumors

Anger, J.T.; Saigal, C.S.; Wang, M.; Yano, E.M., 2008:
Urologic disease burden in the United States: veteran users of Department of Veterans Affairs healthcare

Basiri,A.; Mousavi,S.M.; Naghavi,M.; Araghi,I.A.; Namini,S.A., 2008:
Urologic diseases in the Islamic Republic of Iran what are the public health priorities?

King, L.R., 1990:
Urologic disorders

Ishibashi, A., 1991:
Urologic disorders and abdominal pain

Bellinger, M.F., 1991:
Urologic disorders in children

Perez, L.M.; Barnes, N.; Webster, G.D., 1992:
Urologic dysfunctions of patients with tethered cord secondary to diastematomyelia splitting of the spinal cord

Marberger, H.Jr; Pavone, M., 1989:
Urologic endoscopy

Delamarter, R.B.; Bohlman, H.H.; Bodner, D.; Biro, C., 1990:
Urologic function following experimental cauda equina compression cystometrograms vs cortical evoked potentials

Bernsley, C.N.; Elder, J.S., 1992:
Urologic imaging in the pediatric patient

Van der Pijl, J.W.; Smets, Y.F.; de la Fuente, R.; Ringers, J.; Lemkes, H.H.; van der Woude, F.J., 1995:
Urologic infections and problems after 50 simultaneous pancreas-kidney transplantations

Lins, C.O.N.; Monteiro, L.M.C.sta, 1998:
Urologic investigation in myelodysplastic children in the first year of life

Decter, R.M.; Bauer, S.B., 1993:
Urologic management of spinal cord injury in children

Konchanin, R.P.; Fisher, H.A.G.; Bennett, A.H., 1989:
Urologic manifestation of the acquired immune deficiency syndrome

Bauer, S.B.; Atala, A.; Shefner, J.M.; Shillito, J.; Scott, R.M., 1992:
Urologic manifestations in patients with diastematomyelia

Park, C.H.; Ryu, D.S.; Kim, K.S.; Cho, W.H.; Park, S.B.; Kim, H.C., 1994:
Urologic morbidity of vesicoureteral reflux in the renal transplantation candidate

Yoshida, O., 1991:
Urologic oncology in Japan: current status and future direction

Mcguire, E.J.; Noll, F.; Vasher, E., 1990:
Urologic outcome after spinal cord injury

Garcia Morata, F.; Garcia Torres, M.L.; Garay Burdeos, M.; Porras Robles, F.; Garay Lillo, J., 1991:
Urologic pathology in the geriatric patient

Shandera, K.C.; Thompson, I.M., 1994:
Urologic prostheses

Cetinel, B.; Obek, C.; Solok, V.; Yaycioglu, O.; Yazici, H., 1998:
Urologic screening for men with Behcets syndrome

McCarty, T.; Roberts, L.W.; Hendrickson, K., 1996:
Urologic sequelae of childhood genitourinary trauma and abuse in men: principles of recognition with fifteen case illustrations

Ahlering, Thomas, E., 1997:
Urologic surgery and trauma

Oesterling, J.E.; Lieber, M.M.; Panser, L.A.; Epstein, R.S.; Schwartz, S.W.; Chute, C.G., 1991:
Urologic symptoms and quality of life associated with benign prostatic hyperplasia bph

Mcaleer, I.M.; Kaplan, G.W.; Packer, M.G.; Scherz, H.C.; Lynch, F., 1992:
Urologic trauma in the pediatric patient

Gallo, S.; Eshghi, M.; Davidson, S.; Butt, K.; Tomasula, J.; Mallouh, C., 1998:
Urologic treatment of renal transplant complications

Heyman, A.M., 1990:
Urologic uses of the bed BUG

Kanoun, F.; Hamed, S.B.n; Maaloul, I.; Mustapha, A., 1993:
Urological abnormalities revealed by upper urinary tract infection

Mannion, Rodney, A., 1998:
Urological allusion in the works of William Shakespeare

Epifanov, N.S.; Papikyan, A.I., 1993:
Urological and nephrological complications in patients with blood diseases

Bagley, D.; Erhard, M., 1994:
Urological application of the Holmium laser Preliminary experience

Braun, P.M.rtin; Koehrmann, K.U.e; Michel, M.S.ephan; Marlinghaus, E.H.; Alken, P., 1998:
Urological application of the Minilith SL2

Patel, A.; Fuchs, G.J., 1996:
Urological applications of endoluminal ultrasound , the UCLA experience with ureteral strictures

Noeske, H.D.eter; Weidner, W., 1998:
Urological aspects in the surgery of Larrey

Reinberg, Y.; Bumgardner, G.L.; Aliabadi, H., 1990:
Urological aspects of renal transplantation

Reinberg, Y.; Manivel, J.C.; Long, R.J.; Resnick, J.; Simonton, S.; Gonzalez, R., 1992:
Urological aspects of sacrococcygeal teratoma

Solheim, B.; Larsen, A.; Bjerklund Johansen, T.E.; Urnes, T., 1993:
Urological aspects of vesicointestinal fistula

Chitale, S.V.; Almeida, A.; Hadfield, J.I., 1997:
Urological complication of pelvic fracture treated by an external fixator

Zavos, G.; Pappas, P.; Karatzas, T.; Karidis, N.P.; Bokos, J.; Stravodimos, K.; Theodoropoulou, E.; Boletis, J.; Kostakis, A., 2008:
Urological complications: analysis and management of 1525 consecutive renal transplantations

Mäkisalo, H.; Eklund, B.; Salmela, K.; Isoniemi, H.; Kyllönen, L.; Höckerstedt, K.; Halme, L.; Ahonen, J., 1997:
Urological complications after 2084 consecutive kidney transplantations

Doublet, J.D.; Gattegno, B.; Coloby, P.; D'acremont, B.; Thibault, P., 1993:
Urological complications after ileal neobladder

Douzdjian, V.; Gugliuzza, K.K.; Fish, J.C., 1995:
Urological complications after simultaneous pancreas-kidney transplantation Hand-sewn vs stapled duodenocystostomy

Junjie, M.; Jian, X.; Lixin, Y.; Xiwen, B., 1998:
Urological complications and effects of double-J catheter in ureterovesical anastomosis after cadaveric kidney transplantation

Ploeg, R.J.; Eckhoff, D.E.; D'Alessandro, A.M.; Stegall, M.D.; Knechtle, S.J.; Pirsch, J.D.; Sollinger, H.W.; Belzer, F.O., 1994:
Urological complications and enteric conversion after pancreas transplantation with bladder drainage

Gettman, M.T.; Levy, J.B.; Engen, D.E.; Nehra, A., 1997:
Urological complications and patient/graft survival following kidney/pancreas transplantation

Broseta, E.; Boronat, F.; Ruiz, J.L.; Alonso, M.; Osca, J.M.; Jiménez-Cruz, J.F., 1991:
Urological complications associated to uterus didelphys with unilateral hematocolpos. A case report and review of the literature

Howe, S.F.; Lowell, J.; Bynon, J.S.; Stratta, R.J.; Taylor, R.J., 1993:
Urological complications associated with bladder drained pancreas transplants

Petri, E., 1989:
Urological complications diagnosis and treatment of therapeutic complications

Ciancio, G.; Burke, G.W.; Nery, J.; Siquijor, A.; Coker, D.; Roth, D.; Miller, J., 1995:
Urological complications following simultaneous pancreas-kidney transplantation

Kekec, Y.; Tokyay, R.; Tavli, S.; Bilgin, N.; Haberal, M., 1992:
Urological complications in 884 consecutive transplants

Levine, L.A.; Richie, J.P., 1989:
Urological complications of cyclophosphamide

Piazza, R.; Pollastri, C.A.; Artibani, W., 1998:
Urological complications of minimally invasive surgery

Hernandez-Siverio, N.; Gomez Culebras, M.A.; Losada Cabrera, M.; Rodriguez Hernandez, P.; Gutierrez Hernandez, P.; Rodriguez de Vera, J.M.; Castro Diaz, D.; Ravina Pisaca, M.; Arteaga Serrano, F.; Bañares Baudet, F., 1992:
Urological complications of renal transplantation at the H.U.C

Crowley, I.P., 1989:
Urological device us patent 4799928 january 24 1989

Kondo, A., 1994:
Urological diseases in the aged

Valentino, L.; Conforti, R.; Avino, G.; Majorana, M.; Straface, A.; Orbinato, F.; Magri, D.; Lama, G., 1995:
Urological dysfunction and diastematomyelia

Giannantoni, A.; Scivoletto, G.; Finazzi Agro, E.; Silecchia, A.; D.S.asi, S.M.; Fuoco, U.; Mollo, A.; Ipektchi, L.; Castellano, V., 1997:
Urological dysfunctions and upper urinary tract involvement in multiple sclerosis patients

Schwieker, H., 1996:
Urological examination apparatus

Steffens, J.; Humke, U., 1995:
Urological geriatrics

Petry, James, L., 1993:
Urological implications of the filibuster

Maloney, M.; Demoucell, P.J.; Oheigeartaigh, M., 1991:
Urological interventions impact in the treatment of the incontinent stroke patient

Williams, R.D., 1992:
Urological laboratory examination

Colegrove, P.M.; Winfield, H.N.; Donovan, J.F.; See, W.A., 1998:
Urological laparoscopic practice patterns 5 years after formal training

Winfield, H.N.; Donovan, J.F.; See, W.A.; Loening, S.A.; Williams, R.D., 1991:
Urological laparoscopic surgery

Baron, J.C.; Delmas, V.; Dauge, M.C.; Boccon Gibod, L., 1991:
Urological manifestations of acquired immunodeficiency syndrome aids

Maio, G.; Aragona, F.; Cisternino, A.; Calabrò, A.; Ostardo, E.; Artibani, W., 1992:
Urological manifestations of acute appendicitis: report of two new cases

Shenot, P.J.; Rivas, D.A.; Mandel, S.; Schwartzman, R.J.; Chancellor, M.B., 1994:
Urological manifestations of reflex sympathetic dystrophy versus interstitial cystitis

Cunningham, L.N.; Keating, M.A.; Snyder, H.M.; Duckett, J.W., 1989:
Urological manifestations of the popliteal pterygium syndrome

Foster, M.C.; Upsdell, S.M.; O'Reilly, P.H., 1990:
Urological myths

Takamoto, S., 1995:
Urological peritonitis

Meyers, K.E.C.; Thomson, P.D.; Beale, P.G., 1993:
Urological problems in 162 pediatric renal transplant patients

Lin, R.; Klimberg, I.; Alpin, M.; Elfenbein, G.; Weiner, R., 1989:
Urological problems in bone marrow transplant patients

Culibrk, B.; Fehir, L., 1996:
Urological spiral PORGES The definitive solution of the complete urine retention with benign prostatic hypertrophy

Flomenblit, J.; Budigina, N., 1997:
Urological stent and deployment device therefor

Mikus, P.; Moseley, W., 1998:
Urological stent therapy system and method

Peters, H.J., 1992:
Urological symposium on prostate cancer

Herrmann, K.; Krauss, G., 1996:
Urological workstation

Steinbach, F.; Thueroff, J.W.; Hohenfellner, M.; Schweden, F.; Hohenfellner, R., 1990:
Urologically relevant vascular abnormalities

Ebert, A.K.; Brookman-Amissah, S.; Roesch, W.H., 2008:
Urologische Manifestationen des Down-Syndroms Bedeutung und Langzeitkomplikationen - eigenes Patientengut mit Ubersicht

Fuchs, E.F.; Lashley, D., 1996:
Urologist-acquired renal-access for percutaneous ultrasonic lithotripsy

Osada, Takao, 1993:
Urologists approach to psychotherapy for impotence

Teichman, J.M.H.; Vassar, G.J.; Angle, B.; Johnson, A.J.; Dirks, M.S.; Thompson, I.M.; Pearle, M.S., 1997:
Urologists risk color confusion during laser applications using CO-2, coumarin green, or KTP but not with HolmiumYAG or NdYAG lasers

Böhlen, D.; Hochreiter, W.W.; Thalmann, G.N.; Danuser, H.J., 1998:
Urology: sperm production and prostate reduction

Osada, T., 1990:
Urology and psychosomatic medicine

Popovkin, N.N.; Martov, A.G.; Chernov, N.A.; Golovanov, S.A.; Komarova, V.A., 1997:
Urology in Internet

Hamilton, J.Nathaniel.; Rovner, E.S.; Turner, W.R., 2008:
Urology in pre-civil war Charleston

Weigel, J.W.; Weaver, R.P.; Wettlaufer, J.N., 1990:
Urology in the vietnam conflict

Montie, J.; Faerber, G.; Schaeffer, A.; Steers, W.; Liebert, M.; Stoll, D.; Macoska, J., 2008:
Urology residency and research: round table discussion and plea for innovation

Gettman, M.T.; Karnes, R.Jeffrey.; Arnold, J.J.; Klipfel, J.M.; Vierstraete, H.T.; Johnson, M.E.; Johnson, D.R.; Leibovich, B.C., 2008:
Urology resident training with an unexpected patient death scenario: experiential learning with high fidelity simulation

Breda, G.; Xausa, D.; Puppo, P.; Ricciotti, G.; Zanollo, A.; Guadaloni, P.; Rigatti, P.; Guazzoni, G.; Franch, L., 1993:
Urolume in the urethral stenosis The UMI-club experience

Chancellor, M.B.; Vivas, C.A.; Rivas, D.A.; Crewalk, J.A.n; Wuinn, D.A.; Bennett, C.; Simoneau, A.; Finocchiaro, M.V.; Razi, S.; Bennett, J.K.; Foote, J.E.; Green, B.G.; Killorian, R.W.lly, 1997:
Urolume stent versus external sphincterotomy in SCI patients Prospective randomized multicenter study

Juma, S.; Joseph, A.; Niku, S.D.niel, 1994:
Urolume urethral prosthesis in the treatment of detrusor sphincter dyssynergia

Milroy, Euan, 1994:
Urolume wallstent for urethral strictures Long term results

Lucas, W.G., 1993:
Urolume wallstent in prostatic obstruction

Behne, L., 1990:
Urometopus penevi new species a new weevil species from bulgaria insecta coleoptera curculionidae otiorhynchidae

Sherblom, A.P.; Smagula, R.M.; Moody, C.E.; Rosen, C.J., 1989:
Uromodulin mediated clearance of interleukin 1 in osteopenia

Arkwright, P.D.; Rademacher, T.W.; Dwek, R.A.; Marshall, J.; Redman, C.W.G., 1992:
Uromodulin or a closely related protein is associated with the syncytiotrophoblast membrane of the human term placenta

Parmelee, J.A.; Savile, D.B.O., 1990:
Uromyces geranii

Perez Uz, B.; Song, W., 1995:
Uronema gallicum sp n a new marine scuticociliate from the coastal area of Calais

Timoshchuk, V.A., 1995:
Uronic acid nucleosides as part of natural antibiotics

Pressey, R., 1991:
Uronic acid oxidase in plants

Hilbert, D.W.; Pascal, K.E.; Libby, E.K.; Mordechai, E.; Adelson, M.E.; Trama, J.P., 2008:
Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway

Braila, M.G., 1989:
Uropathogenicity of escherichia coli

Acosta, Luis Eduardo, 1998:
Urophonius transandinus sp nov , a scorpion from Central Chile

Lang, R.F.; Richard, R.D.; Hansen, R.W., 1997:
Urophora affinis and U quadrifasciata released and monitored by USDA, APHIS, PPQ as biological control agents of spotted and diffuse knapweed

Woodburn, T.L.; Sheppard, A.W., 1996:
Urophora solstitialis, a potential biological control agent for Carduus nutans in Australia

Li, S.M.; Zhang, Z.T.ng; Chan, S.; Mcclenan, O.; Lepor, H.; Dixon, C.; Sun, T.T.en; Wu, X.R., 1998:
Uroplakin II as a specific marker of metastatic transitional cell carcinoma

Wu, X.R.; Moll, R.; Lin, J.H.iang; Yu, J.; Sun, T.T.en, 1996:
Uroplakins as tissue-specific and differentiation-dependent markers of normal urothelium and bladder carcinomas

Lourenco, Wilson, R., 1998:
Uroplectoides abyssinicus gen n, sp n, a new genus and new species of scorpion from Ethiopia

Weirich, D.; Ziegler, A., 1997:
Uropod and lateral plate glands of the terrestrial isopod Porcellio scaber Latr An ultrastructural study

Munoz, E.; Alvarez, V.; Alsono, J.L.; Serrador, J.; Traver, J.A.; Sanchez, F., 1998:
Uropod formation A new mechanism of neutrophil recruitment contributing to hemodialysis-induced neutropenia

Asplin, J.R.; Hoyer, J.; Gillespie, C.; Coe, F.L., 1995:
Uropontin inhibits aggregation of calcium oxalate monohydrate crystals

Asplin, J.; Hoyer, J.R.; Nakagawa, Y.; Coe, F.L., 1992:
Uropontin inhibits calcium oxalate monohydrate crystal growth and nucleation

Sinclair, P.R.; Gorman, N.; Dalton, T.; Walton, H.S.; Bement, W.J.; Sinclair, J.F.; Smith, A.G.; Nebert, D.W., 1998:
Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice

Xu, W.; Astrin, K.H.; Desnick, R.J., 1994:
Uroporphyrinogen III synthase Molecular cloning, nucleotide sequence, and expression of a full-length murine cDNA

Philips, J.D.; Whitby, P.G.; Kushner, J.P., 1997:
Uroporphyrinogen decarboxylase is a dimer

Warren, M.; Gonzalez, M.D.; Williams, H.J.; Stolowich, N.J.; Scott, A.I., 1990:
Uroporphyrinogen iii methylase catalyzes the enzymatic synthesis of sirohydrochlorins ii and iv by a clockwise mechanism

A.H.idary A.D.; Mackay, I.G.; Bhoola, K.D.; Millar, N.D.; Mackenzie, J.C., 1992:
Uroprostaglandin excretion during water immersion in renal allograft recipients

Griffith, D.P.; Gleeson, M.J.; Wong, H.Y.n; Wang, L., 1997:
Uroprostheses Proof of principal

Morin, D.; Veyrac, C.; Lyonnet, F.; Dalla Vale, F.; Durand, M.F.; Astruc, J.; Dumas, R., 1996:
Uroradiologic evaluation in first-time acute pyelonephritis occurring without obvious uropathy

Sreenarasimhaiah, V.; Alon, U.S., 1994:
Uroradiologic evaluation of children with urinary tract infection Are both ultrasonography and renal cortical scintigraphy necessary

Zucker, Naida, 1992:
Urosaurus ornatus Mortality

George, P.; Borg, F.; O'connor, S.; Lechaire, J.; Arbilla, S.; Pimoule, C.; Graham, D.; Wedzikowsky, T.; Langer, S.Z., 1995:
Uroselective alpha-1-adrenoceptor antagonists for the treatment of benign prostatic hypertrophy

Persky, L.; Liesen, D.; Yangco, B., 1989:
Urosepsis and resistant staphylococci patterns of prevention

Steer, P.L., 1989:
Urostomy appliance us patent 4867749 september 19 1989

O'laughlin, G.S.; O'laughlin, P.K., 1997:
Urostomy collector cleaning attachment

Rower, G., 1998:
Urostomy patient equipment irrigation system

Lu, W.; Abdel-Razik, A.E.S.; Ashton, N.; Balment, R.J., 2008:
Urotensin II: lessons from comparative studies for general endocrinology

Prosser, H.C.G.; Forster, M.E.; Richards, A.M.; Pemberton, C.J., 2007:
Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury

Malagon, M.M.; Molina, M.; Gahete, M.D.; Duran-Prado, M.; Martinez-Fuentes, A.J.; Alcain, F.J.; Tonon, M-Christine.; Leprince, Jérôme.; Vaudry, H.; Castaño, J.P.; Vazquez-Martinez, R., 2008:
Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5

Waugh, D.; Youson, J.; Mims, S.D.; Sower, S.; Conlon, J.M.chael, 1995:
Urotensin II from the river Lamprey , the sea lamprey , and the Paddlefish

Chartrel, N.; Conlon, J.M.; Collin, F.; Braun, B.; Waugh, D.; Vallarino, M.; Vaudry, H., 1998:
Urotensin II in the central nervous system of the frog Rana ridibunda. Biochemical characterization and immunohistochemical localization

Zhang, Y-Gang.; Li, J.; Li, Y-Guang.; Wei, R-Hong., 2008:
Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta

Loirand, G.; Rolli-Derkinderen, M.; Pacaud, P., 2008:
Urotensin-II and atherosclerosis

Papadopoulos, P.; Bousette, N.; Giaid, A., 2007:
Urotensin-II and cardiovascular remodeling

Oka, S.; Chiba, A.; Honma, Y., 1992:
Urotensin-like immunoreactivity in the nervous system of lower vertebrates and invertebrates

Lips, Karen, R., 1993:
Urotheca myersi

Hofstaedter, F., 1995:
Urothelial atypia and dysplasia

Abdel Razzak, O.M.; Ehya, H.; Cubler Goodman, A.; Bagley, D.H., 1992:
Urothelial biopsy using endoscopes with a 3f working channel comparison of techniques

Katz, R.; Golijanin, D.; Landau, E.H.; Meretyk, S., 1997:
Urothelial cancer of the renal pelvis in PCNL patients

Carroll, P.R., 1992:
Urothelial carcinoma cancers of the bladder ureter and renal pelvis

Erroll, M.; Vakil, B.; Hoda, R.S., 1998:
Urothelial carcinoma cells may appear smaller, pyknotic or spindly and may be obscured by inflammatory cells on ThinPrep

Grainger, R.; Gikas, P.W.; Grossman, H.B., 1990:
Urothelial carcinoma occurring within an inverted papilloma of the ureter

Zigeuner, R.; Pummer, K., 2008:
Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors

Alexander, T.G.; Terris, M.K.; Staack, A.; Best, C.D.; Merguerian, P.A., 1997:
Urothelial cell dependence upon fibroblasts for growth in cell culture

Dhindsa, A.; Fowler, J.Jr; Lynes, W.; Ghosh, L., 1990:
Urothelial collagen type iv and fibronectin in interstitial cystitis

Akiyama, A.; Stein, P.C.; Parsons, C.L.well, 1997:
Urothelial cytoprotective activity of Tamm-Horsfall protein from interstitial cystitis and normal urine

Rabah, R.; Vates, T.; Denes, E.; Suzer, O.; Freedman, A.; Gonzalez, R., 1997:
Urothelial expansion on seromuscular colonic segments in the canine

Mincione, G.P., 1990:
Urothelial grade I atypia

See, W.A.; Williams, R.D., 1992:
Urothelial injury and clotting cascade activation: common denominators in particulate adherence to urothelial surfaces

Fitko, R.; Gallagher, L.; Gonzalez-Crussi, F.; Oyasu, R., 1991:
Urothelial leiomyomatous hamartoma of the kidney

Rahilly, M.A.; Jenkins, D.A.; Carey, F.A., 1992:
Urothelial neoplasia complicating acquired cystic kidney disease

Cohen, S.M.; Arnold, L.L.; S.J.hn, M.K.; Cano, M.; Smith, R.A.; Sangha, G.; Christenson, R., 1997:
Urothelial proliferation induced by high doses of o-phenylphenol in male rats

O'Sullivan, D.; Barrett, D.M., 1993:
Urothelial substitutes: bladder

Kavoussi, L.R., 1993:
Urothelial substitutes: ureter

Hutton, K.A.; Trejdosiewicz, L.K.; Thomas, D.F.; Southgate, J., 1993:
Urothelial tissue culture for bladder reconstruction: an experimental study

Atala, A.; Yoo, J.J., 1997:
Urothelial tissue engineered neo-organs A novel vehicle for gene delivery

Bocharova, O.A.; Serebryakova, R.V.; Golubeva, V.A.; Figurin, K.M.; Bukharkin, B.V.; Bodrova, N.B.; Matveev, B.P.; Baryshnikov, A.Y., 1994:
Urothelial tissue mechanical integration and immune parameters of patients with bladder tumors

Lipschutz, J.H.; Young, P.; Cunha, G.R., 1994:
Urothelial transformation in situ

Amin, M.B.; Gomez, J.A.; Young, R.H., 1997:
Urothelial transitional cell carcinoma with endophytic growth patterns

Androulakakis, P.A.; Davaris, P.; Karayannis, A.; Michael, V.; Aghioutantis, C., 1992:
Urothelial tumors of the bladder

Liu, S.; Leung, H.; Considine, J., 1992:
Urothelial tumour of renal pelvis in patient with crossed ectopia

Lavelle, J.P.; Zeidel, M.L., 1997:
Urothelial water and urea diffusive permeability in inflamed guinea pig bladders

Wang, X.; Momota, Y.; Yanase, H.; Narumiya, S.; Maruyama, T.; Kawatani, M., 2008:
Urothelium EP1 receptor facilitates the micturition reflex in mice

Hellström, A.L., 1992:
Urotherapy in children with dysfunctional bladder

Rankin, G.O.; Teets, V.J.; Nicoll, D.W.; Brown, P.I., 1990:
Urotoxicity induced by succinimide antiepileptic agents potentiation by phenobarbital

Lopez, S.Myrna, I.; Bussing, W.A., 1998:
Urotrygon cimar, a new eastern Pacific stingray

Clay, C.G.; Greeff, A.S.; Crewe Brown, H.H.; D.V.lliers, B.; Blanco, M.; Gonzalez, E.A.; Blanco, J., 1994:
Urovirulent Escherichia coli from south Africa produce cytotoxic necrotizing factor type 1 and have cell adherence properties

Shimokura, G.H.; Mcgill, J.M.; Fitz, J.G., 1994:
Ursodeoxycholate activates Cl- currents in biliary cells through a Ca-2+-dependent mechanism

Tabouy, L.; Zamora, A.J.; Oliva, L.; Montet, A.M.; Beauge, F.; Montet, J.C., 1998:
Ursodeoxycholate alleviates alcohol-induced liver mitochondrial injury

Oliva, L.; Beaugé, F.; Choquart, D.; Montet, A.M.; Guitaoui, M.; Montet, J.C., 1998:
Ursodeoxycholate alleviates alcoholic fatty liver damage in rats

Wali, R.; Skarosi, S.; Hart, J.; Bissonnette, M.; Sitrin, M.; Brasitus, T., 1998:
Ursodeoxycholate and a fluorinated analogue of 1,25-dihydroxyvitamin D3 inhibit aberrant crypt formation in the azoxymethane model of rat colonic carcinogenesis

Kwo, P.Y.; Gores, G.J., 1994:
Ursodeoxycholate and its conjugates protect against glycodeoxycholate-induced apoptosis

Nomura, T.; Tsukada, K.; Higashi, K.; Yamada, J.; Hoshino, M.; Isobe, T.; Nakayama, Y.; Nakao, H.; Takeuchi, T.; Hoek, J.B., 1993:
Ursodeoxycholate and protein kinases modulate the chenodeoxycholate-induced intracellular signaling in isolated rat hepatocytes

Kano, M.; Shoda, J.; Ueda, T.; Ikegami, T.; Matsuzaki, Y.; Asano, T.; Tanaka, N., 1997:
Ursodeoxycholate attenuates enhanced expression levels in gallbladder group II phospholipase A-2 and reduces biliary protein and viscosity in patients with multiple cholesterol stones

Spivey, J.R.; Vadakekalam, J.; Gores, G.J., 1992:
Ursodeoxycholate cytoprotection against hepatocyte killing by hydrophobic bile salts cannot be explained solely by changes in the hydrophobicity index

Kraehenbuehl, S.; Talos, C.; Fischer, S.; Reichen, J., 1993:
Ursodeoxycholate decreases mitochondrial toxicity and membrane incorporation of lipophilic bile acids

Washabau, R.J.; Khandelwal, M.; Malet, P.F., 1993:
Ursodeoxycholate diminishes myosin light chain phosphorylation and active isometric stress in guinea pig gallbladder smooth muscle

Baumgartner, U.; Schoelmerich, J., 1991:
Ursodeoxycholate does not prevent bile acid toxicity on freshly isolated rat hepatocytes

Muldoon, J.; Greiner, M.; Matsumara, J.; Nahrwold, D.; Dawes, L., 1993:
Ursodeoxycholate infusion increases bile acid and bilirubin output in miniswine on TPN

Baiocchi, L.; Alpini, G.; Galser, S.; Francis, H.; Phinizy, J.; Rodgers, R.; Eisel, W.; Lesage, G., 1998:
Ursodeoxycholate inhibits the increased cholangiocyte secretion and proliferation in bile duct ligated rats

Botla, R.; Spivey, J.R.; Bronk, S.F.; Gores, G.J., 1994:
Ursodeoxycholate inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate A mechanism for ursodeoxycholate cytoprotection?

Guelduetuna, S.; Deisinger, B.; Sippos, P.; Weiss, A.; Freisleben, F.; Leuschner, U., 1994:
Ursodeoxycholate mimics the effect of cholesterol on the phase transition of egg yolk lecithin

Guelduetuna, S.; Weiss, A.; You, T.; Bhatti, S.; Freisleben, F.; Leuschner, U., 1994:
Ursodeoxycholate mimics the membrane stabilizing effect of cholesterol on large unilamellar vesicles

Nomura, T.; Tsukada, K.; Hoshino, M.; Saso, K.; Nakayama, Y.; Isobe, T.; Takahashi, Y.; Nakao, H.; Takeuchi, T.; Hoek, J.B., 1994:
Ursodeoxycholate modulates the chenodeoxy-cholate-induced intracellular signalling in isolated hepatocytes

Nakayama, Y.; Tsukada, K.; Hoshino, M.; Higashi, K.; Nomura, T.; Saso, K.; Isobe, T.; Takashashi, Y.; Nakao, H.; Takeuchi, T.; Hoek, J.B., 1994:
Ursodeoxycholate modulates the receptor-mediated phospholipase C activation in isolated hepatocytes

Shinozaki, H.; Abe, Y.; Miyasaka, K.; Funakoshi, A.; Kanno, T., 1995:
Ursodeoxycholate potentiates cholecystokinin -induced -c dynamics and secretory response but not CCK-JMV-180-induced responses in dispersed perifused acini of the rat pancreas

Guelduetuna, S.; Elze, A.; Bhatti, S.; Imhof, M.; You, T.; Zimmer, G.; Leuschner, U., 1993:
Ursodeoxycholate prevents glutamate dehydrogenase release of isolated liver mitochondria by chenodeoxycholate

Salvioli, G.; Panini, R.; Lugli, R., 1990:
Ursodeoxycholate protection against the hemolysis induced by other detergents

Galle, P.R.; Theilmann, L.; Raedsch, R.; Kommerell, B.; Stiehl, A., 1990:
Ursodeoxycholate reduces hepatotoxicity of glycochenodeoxycholate in primary human liver cells part ii

Galle, P.R.; Theilmann, L.; Kohl, B.; Raedsch, R.; Stiehl, A., 1989:
Ursodeoxycholate reduces toxicity of different bile acids in human primary hepatocytes cultures

Galle, P.R.; Theilmann, L.; Raedsch, R.; Stiehl, A., 1989:
Ursodeoxycholate reduces toxicity of glycochenodeoxy cholate in human primary hepatocytes cultures

Bhatti, S.; Elze, A.; Guelduetuna, S.; Leuschner, U., 1994:
Ursodeoxycholate retards glutamate dehydrogenase release from isolated liver mitochondria by chenodeoxycholate , but does not preserve mitochondrial structure

Nakayama, Y.; Tsukada, K.; Hoshino, M.; Nomura, T.; Higashi, K.; Isobe, T.; Takahashi, Y.; Nakao, H.; Takeuchi, T.; Hoek, J.B., 1994:
Ursodeoxycholate suppresses the stimulatory effect of protein kinase A on hormone-mediated phospholipase C activation in isolated rat hepatocytes

Bissonnette, M.; Johnson, J.; Wexler, S.; Skarosi, S.; Wali, R., 1997:
Ursodeoxycholate, a chemopreventive bile salt in colonic carcinogenesis, stimulates apoptosis and inhibits Bcl-2 expression in Caco-2 cells

Miyake, H.; Tazuma, S.; Miura, H.; Hattori, Y.; Kajihara, T.; Nishioka, T.; Hyogo, H.; Sunami, Y.; Yasumiba, S.; Ochi, H.; Yamashita, G.; Kajiyama, G., 1998:
Ursodeoxycholate, but not other cytoprotective bile acids, reduces biliary arachidonyl-lecithin secretion, and thereby stabilizes a physical chemical state of bile lipids

Batta, A.K.; Salen, G.; Rapole, K.R.; Holubek, H.; Earnest, D., 1995:
Ursodeoxycholic acid , a hydrophilic bile acid, is concentrated in the water soluble fraction of feces

Batta, A.K.; Salen, G.; Alberts, D.; Reid, M.; Morales, T.; Earnest, D., 1997:
Ursodeoxycholic acid , a hydrophilic bile acid, suppresses the proportion of deoxycholic acid in the water soluble fraction in human stool

Roman, R.; Schlenker, T.; Fitz, J.G., 1997:
Ursodeoxycholic acid activates Ca2+- dependent Cl- currents in a human biliary cell line

Sama, C.; Mazziotti, A.; Grigioni, W.; Morselli Labate, A.M.; Chianura, A.; Stefanini, G.F.; Barbara, L.; Gozzetti, G., 1991:
Ursodeoxycholic acid administration does not prevent rejection after olt

Baruch, Y.; Weisbuch, F.; Assy, N.; Reisner, S.; Gaitini, D.; Blendis, L.M.; Bomzon, A., 1996:
Ursodeoxycholic acid affects hyperdynamic circulation in liver cirrhosis

Simko, V.; Michael, S.; Khurana, V., 1997 :
Ursodeoxycholic acid alleviates cholestasis induced by ethinyl estradiol

Koutsos, M.I.; Goldberg, Y.; Krajewski, S.; Reed, J.C.; Shiff, S.J.; Rigas, B., 1997:
Ursodeoxycholic acid alters the expression of p53, BAX, and p21-WAF-1/cip1 in human colon adenocarcinoma cells

Boigk, G.; Stroedter, L.; Herbst, H.; Waldschmidt, J.; Riecken, E.O.; Schuppan, D., 1997:
Ursodeoxycholic acid ameliorates parameters of cholestasis, but does not prevent collagen accumulation in rat secondary biliary liver fibrosis

Kullmann, F.; Arndt, H.; Zach, R.; Rueschoff, J.; Schoelmerich, J.; Gross, V., 1997:
Ursodeoxycholic acid ameliorates, but chenodeoxycholic acid exacerbates indomethacin induced inflammation in rats

Puoti, C.; Pannullo, A.; Annovazzi, G.; Filippi, T.; Magrini, A., 1993:
Ursodeoxycholic acid and chronic hepatitis C infection

Hofmann, M.; Zgouras, D.; Samaras, P.; Spiro, P.; Goekce, Y.; Zimmer, G.; Guelduetuna, S.; Leuschner, U., 1997:
Ursodeoxycholic acid and hyodeoxycholic acid reduce the rate constants of chenodeoxycholic acid Investigations on liver cell protection

Lindor, K.D.; Jorgensen, R.A.; Anderson, M.L.; Gores, G.J.; Larusso, N.F., 1994:
Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis A pilot study

Bouchard, G.; Tuchweber, B.; Yousef, I.M., 1990:
Ursodeoxycholic acid and not tauroursodeoxycholic acid prevents the ethynylestradiol induced intrahepatic cholestasis in rats

Rigas, B.; Tsioulias, G.J.; Allan, C.; Wali, R.; Brasitus, T.A., 1994:
Ursodeoxycholic acid and piroxicam up-regulate MHC antigen expression in rat colonocytes during colon cancer development

Leuschner, M.; Guelduetuna, S.; Huebner, K.; You, T.; Leuschner, U., 1996:
Ursodeoxycholic acid and prednisolone in the treatment of primary biliary cirrhosis Results of a controlled double-blind trial

Arndt, H.; Palitzsch, K.D.; Kullmann, F.; Gross, V.; Gruene, S.; Schoelmerich, J., 1995:
Ursodeoxycholic acid attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat

D.L.dinghen, V.; Barrioz, T.; Ingrand, P.; Silvain, C.; Beauchant, M., 1994:
Ursodeoxycholic acid combined with norfloxacin prevented polyethylene stent occlusion A randomized trial

Ventura, P.; Panini, R.; Montosi, G.; Garuti, C.; Vandelli, M.A.; Brunetti, G.; Pietrangelo, A.; Salvioli, G., 1998:
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats

Lindor, K.D.; Jorgensen, R.A.; Dickson, E.R., 1995:
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis

Reiner, A., 1989:
Ursodeoxycholic acid derivatives and their inorganic and organic salts having therapeutic activity and process for preparing the same us patent 4865765 september 12 1989

Leuschner, U.; Guelduetuna, S.; Imhof, M.; Leuschner, M., 1992:
Ursodeoxycholic acid does not cure primary biliary cirrhosis but prolongs survival time Results of a 3-11 years study

Narkewicz, M.R.; Sokol, R.J.; Smith, D.; Gregory, C.; Lear, J.L., 1992:
Ursodeoxycholic acid does not improve quantitative tests of hepatic function in children with intrahepatic cholestasis despite clinical improvement

Boigk, G.; Herbst, H.; Jia, J.D.; Riecken, E.O.; Schuppan, D., 1997:
Ursodeoxycholic acid does not influence the number or distribution of desmin-positive non-parenchyma liver cells in rat biliary fibrosis

Simko, V.; Michael, S., 1994:
Ursodeoxycholic acid does not modify cholestasis induced by alpha-NAPHthylisothiocyanate

Watson, K.J.R.; Roufail, S.; Sotirellis, N.; Breen, K.J.; Desmond, P.V.; Sawyer, W.H., 1991:
Ursodeoxycholic acid does not prevent functional membrane biochemical or histological changes in the chronically bile duct ligated rat

Merrett, M.N.; Jewell, D.P., 1993:
Ursodeoxycholic acid does not protect CaCo-2 cells from bile acid induced cytotoxicity

Alvaro, D.; Mennone, A.; Boyer, J.L., 1992:
Ursodeoxycholic acid does not stimulate bicarbonate excretion from isolated bile duct epithelial cells

Oda, M.; Yokomori, H.; Ishii, K.; Nishizaki, Y.; Inoue, J.; Watanabe, N.; Tsuchiya, M., 1990:
Ursodeoxycholic acid enhances bile canalicular contractions

Gutzler, F.; Zimmermann, R.; Ring, G.H.; Sauer, P.; Stiehl, A., 1992:
Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome

Alpini, G.; Glaser, S.; Caligiuri, A.; Phinizy, J.; Rodgers, R.; Francis, H.; Robertson, W.; Papa, E.; Lasater, J.; Lesage, G., 1998:
Ursodeoxycholic acid feeding inhibits secretin-induced cholangiocyte secretory processes in bile duct ligated rats

Poupon, R.; Podevin, P.; Poupon, R.E., 1996:
Ursodeoxycholic acid for chronic viral hepatitis

Colombo, C.; Podda, M.; Battezzati, P.M.; Santini, B.; Iapichino, L.; Quattrucci, S.; Lucidi, V.; Ferrari, R.; Scotta, S., 1993:
Ursodeoxycholic acid for cystic fibrosis-associated liver disease Final report of a multicenter trial

Poupon, R.; Calmus, Y.; Poupon, R.E., 1992:
Ursodeoxycholic acid for primary biliary cirrhosis effects and mechanisms of action

Van Hoogstraten, H.J.F.; Van, D.M.eberg, P.C.; Wolfhagen, F.H.J.; Kuiper, H.; Hop, W.C.J.; Vanberge Henegouwen, G.P.; Schalm, S.W.; Van Buren, H.R., 1997:
Ursodeoxycholic acid for primary sclerosing cholangitis Results of a 2-year randomized controlled trial evaluating single versus multiple daily doses

Kurosawa, S.; Kuwata, H.; Kushibiki, K.; Kojima, T., 1991:
Ursodeoxycholic acid improved symptom and biochemical data as well as biliary tract sclerosis in primary sclerosing cholangitis

Lacaille, F.; Paradis, K.; Lenaerts, C.; Senechal, L.; Lepage, G.; Roy, C.C.; Rasquin Weber, A., 1993:
Ursodeoxycholic acid improves essential fatty acid deficiency in cystic fibrosis

Lepage, G.; Paradis, K.; Lacaille, F.; Senechal, L.; Ronco, N.; Champagne, J.; Roy, C.C.; Rasquin Weber, A., 1995:
Ursodeoxycholic acid improves hepatic metabolism of essential fatty acid and retinol in cystic fibrosis children

Lepage, G.; Paradis, K.; Lacaille, F.; Senechal, L.; Ronco, N.; Champagne, J.; Brochu, P.; Roy, C.C.; Rasquin, A., 1995:
Ursodeoxycholic acid improves hepatic metabolism of essential fatty acids and retinol in pancreatic cystic fibrosis

Poupon, R.; Balkau, B.; Legendre, C.; Levy, V.G.; Chretien, Y.; Poupon, R.E., 1989:
Ursodeoxycholic acid improves histologic features and progression of primary biliary cirrhosis

Laurin, J.M.; Crippin, J.S.; Gossard, A.; Gores, G.J.; Ludwig, J.; Mcgill, D.B.; Rakela, J.; Lindor, K.D., 1994:
Ursodeoxycholic acid improves indices of liver injury in nonalcoholic steatohepatitis

Caroli Bosc, F.X.; Montet, J.C.; Peten, E.P.; Demuth, N.; Demarquay, J.F.; Delmont, J.P., 1998 :
Ursodeoxycholic acid improves liver and renal biological parametes in liver transplant patients treated with neoral

Hagey, L.R.; Crombie, D.C.; Igimi, H.; Carey, M.C.; Espinosa, E.; Hofmann, A.F., 1991:
Ursodeoxycholic acid in bears occurrence site of formation and biological significance

Beuers, U.; Boyer, J.L.; Paumgartner, G., 1998:
Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications

Palma, J.; Reyes, H.; Ribalta, J.; Hernandez, I.; Sandoval, L.; Silva, O.; Toha, D.; Liepins, J.; Sedano, M.; Almuna, R.; Lira, F.; Silva, J.J., 1996:
Ursodeoxycholic acid in cholestasis of pregnancy Final report of a randomized, double-blind, placebo controlled study

de Caestecker, J.S.; Jazrawi, R.P.; Petroni, M.L.; Northfield, T.C., 1991:
Ursodeoxycholic acid in chronic liver disease

Leuschner, U.; Maier, K.P.; Guldutuna, S.; Parte Peterhans, S.; Leuschner, M., 1997:
Ursodeoxycholic acid in combination with prednisolone or budenoside in the therapy of primary biliary cirrhosis

Floreani, A.; Paternoster, D.; Grella, V.; Sacco, S.; Gangemi, M.; Chiaramonte, M., 1994:
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy

Kouroumalis, E.A., 1991:
Ursodeoxycholic acid in late primary biliary cirrhosis long term follow up

Sama, C.; Morselli Labate, A.M.; Grazi, G.L.; Mastroianni, A.; Danesi, G.; Pianta, P.; Malavolti, M.; Mazziotti, A.; Cavallari, A., 1998:
Ursodeoxycholic acid in liver transplantaion Effect on cholestasis and rejection

Cohen, Murray, H., 1995:
Ursodeoxycholic acid in primary biliary cirrhosis A review

Lo, S.K.; Herrmann, R.; Chapman, R.W.; Fleming, K.A.; Shearman, J.; Cusick, P.; Dooley, J.S., 1992:
Ursodeoxycholic acid in primary sclerosing cholangitis A double-blind placebo controlled trial

Zamboni, L.; Talarico, R.; Labate, A.M.M.rselli; Malavolti, M.; Cicognani, C.; Sama, C.; Barbara, L., 1995:
Ursodeoxycholic acid in the management of primary constipation A cross-over study

Reyes, H., 1997:
Ursodeoxycholic acid in the treatment of cholestasis of pregnancy

Guma, C.L.; Viola, L.A.; Thome, M.; Galdame, O.; D.B.cci, A.; Vaimberg, D., 1998:
Ursodeoxycholic acid in the treatment of gallbladder cholesterol polyps Results of a pilot controlled trial

Guma, C.; Viola, L.; Thome, M.; Galdame, O.; Alvarez, E., 1997:
Ursodeoxycholic acid in the treatment of non-alcoholic Steatohepatitis Results of a prospective clinical controlled trial

Karam, J.A.; Giurgiu, D.I.; Roslyn, J.J.; Abedin, M.Z., 1996:
Ursodeoxycholic acid increases cytosolic free calcium in gallbladder mucosa

Bouscarel, B.; Ceryak, S.; Fromm, H., 1992:
Ursodeoxycholic acid increases hepatic LDL binding under conditions of both up- and downregulation of LDL receptor synthesis

Cincu, R.; Rodriguez Ortigosa, C.M.; Ruiz, F.; Avila, M.A.; Quiroga, J.; Mato, J.M.; Prieto, J., 1998:
Ursodeoxycholic acid increases the more active isoform of methionine adenosyltransferase, a key enzyme in hepatic glutathione production

Martucci, C.P.; Bertagnolli, M.M.; Fishman, J.; Miller, D.G., 1995:
Ursodeoxycholic acid increases tumor incidence in MIN mice

Hirlinger, A.; Saegesser, H.; Reichen, J., 1990:
Ursodeoxycholic acid induced biliary bicarbonate secretion is inhibited by heavy water

Fracchia, M.; Setchell, K.D.R.; Crosignani, A.; Podda, M.; Ferraris, R.; O'connel, N.; Galatola, G., 1993:
Ursodeoxycholic acid induced hypercholeresis in a patient with primary biliary cirrhosis

Stiehl, A.; Raedsch, R.; Moeller, B.; Hopf, U.; Lotterer, E.; Foelsch, U.; Bircher, J., 1989:
Ursodeoxycholic acid induces significant changes of plasma bile acids in primary biliary cirrhosis

Yamazaki, K.; Lindor, K.D.; Batts, K.P.; Szuki, K.; Sato, S.; Kita, H.; Gleich, G.J., 1998:
Ursodeoxycholic acid inhibits eosinophil degranulation in situ in primary biliary cirrhosis

Invernizzi, P.; Salzman, A.L.; Setchell, K.D.R., 1995:
Ursodeoxycholic acid inhibits induction of the human intestinal epithelial nitric oxide synthase

Dominguez Munoz, J.E.; Malfertheiner, P.; Neubrand, M.; Kampmann, S.; Sauerbruch, T., 1995:
Ursodeoxycholic acid inhibits interdigestive duodenal and gallbladder motility, pancreatic secretion and hormone release in man

Crippin, J.S.; Lindor, K.D.; Kluge, D.L.; Homburger, H.A., 1990:
Ursodeoxycholic acid inhibits lymphocyte blastogenesis in a cholestatic model

Yamazaki, K.; Ohtsubo, N.; Kashimoto, T.; Suzuki, K.; Sato, S., 1995:
Ursodeoxycholic acid inhibits mast cell activation in vitro

Invernizzi, P.; Salzman, A.L.; Szabo, C.; Setchell, K.D.R., 1997:
Ursodeoxycholic acid inhibits the induction of inducible nitric oxide synthase in human intestinal epithelial cells

Wolfhagen, F.H.J.; Van Buuren, H.R.; Van Berge Henegouwen, G.P.; Ten Kate, F.J.W.; Den Ouden, J.W.; Kerbert, M.J.; Smit, A.M.; D.V.ies, R.A.; Eskens, F.A.L.M.; Van Haatum, J.; Scherpenisse, J.; Schaim, S.W., 1994:
Ursodeoxycholic acid is beneficial and safe in compensated stage IV primary biliary cirrhosis

Lindor, K.D.L.; Baldus, W.P.; Jorgensen, R.A.; Ludwig, J.; Murtaugh, P.A.; Dickson, E.R., 1992:
Ursodeoxycholic acid is beneficial therapy for patients with primary biliary cirrhosis

Marschall, H.U.; Griffiths, W.G.; Zhang, J.; Wietholtz, H.; Matern, H.; Matern, S.; Sjovall, J., 1993:
Ursodeoxycholic acid is in vivo conjugated with N-acetylglucosamine at the 7-beta-position

Balan, V.; Dickson, E.R.; Jorgensen, R.A.; Lindor, K.D., 1992:
Ursodeoxycholic acid lowers serum cholesterol levels in patients with primary biliary cirrhosis

Beuers, U.; Spengler, U.; Pauletzki, J.; Zwiebel, F.M.; Fischer, S.; Paumgartner, G., 1990:
Ursodeoxycholic acid lowers the pool size of other dihydroxy bile acids in healthy subjects but not in patients with cholestatic liver disease

Baehrle, S.; Szabo, G.; Stiehl, A.; Theilmann, L.; Dengler, T.J.; Zimmermann, R., 1996:
Ursodeoxycholic acid may reduce acute rejection after heart transplantation

Schwarzenberg, S.J.ne; Bundy, M., 1993:
Ursodeoxycholic acid modifies gut-derived endotoxemia

Bouscarel, B.; Adighibe, O.; Griffith, G.S.; Fromm, H., 1997:
Ursodeoxycholic acid modulates calcium-mediated, angiotensin II-induced, glucose fluxes in the perfused liver of golden Syrian hamsters

Abe, K.; Nakadate, I.; Shimotono, H.; Yamazaki, K.; Suzuki, K.; Sato, S., 1992:
Ursodeoxycholic acid modulates cytokine production in primary biliary cirrhosis

Montet, J.C., 1991:
Ursodeoxycholic acid physical properties and hepatoprotective effects

Poo, J.L.; Erlinger, S.; Feldmann, G.; Dumont, M.; Braillon, A.; Lebrec, D., 1989:
Ursodeoxycholic acid prevents biliary cirrhosis and the hyperkinetic circulation induced by bile duct ligation in the rat

Corradini, S.G.nanni; Arancia, G.; Calcabrini, A.; Della Guardia, P.; Baiocchi, L.; Giacomelli, L.; Nistri, A.; Angelico, M., 1992:
Ursodeoxycholic acid prevents cholesterol crystallization in human gallbladder bile by increasing and stabilizing the lamellar carrier

Queneau, P.E.; Montet, A.M.; Guitaoui, M.; Bertault Peres, P.; Montet, J.C., 1993:
Ursodeoxycholic acid prevents chronically cyclosporin A-induced cholestasis without altering the drug concentration in blood A study in the rat

Sharara, A.I.; Camargo, C.A.; Clavien, P.A., 1995:
Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients

Holubec, H.; Earnest, D.; Jolley, C.; Bhattacharyya, A.; Allen, C.; Bissonnette, M.; Wali, R.; Brasitus, T., 1994:
Ursodeoxycholic acid protects against experimental colon cancer

Mitsuyoshi, H.; Nakashima, T.; Sumida, Y.; Yoh, T.; Nakajima, Y.; Ishikawa, H.; Inaba, K.; Sakamoto, Y.; Okanoue, T.; Kashima, K., 1998:
Ursodeoxycholic acid protects hepatocytes against oxidative injury by inducing antioxidants

Friman, S.; Mjörnstedt, L.; Persson, H.; Karlberg, I.; Olausson, M., 1992:
Ursodeoxycholic acid reduces acute rejection in heart allografted rats

Tint, G.S.; Koneru, B.; Stevenson, W.; Batta, A.K.; Shefer, S.; Salen, G., 1993:
Ursodeoxycholic acid reduces elevated plasma endogenous bile acids following orthotopic liver transplant

Barnes, D.; Talenti, D.; Goormastic, M.; Farquhar, L.; Cammell, G.; Henderson, M.; Mayes, J.; Vogt, D.; Westveer, M.; Carey, W., 1995:
Ursodeoxycholic acid reduces hepatic allograft rejection after orthotopic liver transplantation A prospective, randomized, placebo-controlled, double-blind trial

Jüngst, C.; Sreejayan, N.; Zündt, B.; Müller, I.; Spelsberg, F.W.; Hüttl, T.P.; Kullak-Ublick, G.A.; del Pozo, R.; Jüngst, D.; von Ritter, C., 2008:
Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones

Von Ritter, C.; Sreejayan, N.; Mueller, I.; Meyer, G.; Juengst, D., 1998:
Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity of human bile in cholesterol gallstone disease

Shiffman, M.L.; Brugge, W.R.; Malet, P.F.; Khandelwal, M.; Moore, E.W., 1995:
Ursodeoxycholic acid reduces mucin concentration in the gallbladder bile of patients with gallstones

Kullmann, F.; Gross, V.; Rueschoff, J.; Arndt, H.; Mohrenfels, A.W.nkler V.; Benda, W.; Schoelmerich, J., 1995:
Ursodeoxycholic acid reduces mucosal damage in a rat model of inflammatory colitis

Van Erpecum, K.J.; Portincasa, P.; Eckhardt, E.; Vanberge Henegouwen, G.P.; Groen, A.K., 1995:
Ursodeoxycholic acid reduces protein levels and their nucleation promoting activity in gallbladder bile of cholesterol stone patients

Kitani, K.; Kanai, S.; Sato, Y.; Ohta, M.; Nokubo, M., 1993:
Ursodeoxycholic acid reduces the systemic toxicity of 1,2-dichloro-4-nitrobenzene in mice A possible involvement of hepatic glutathione S-transferase

Patel, S.A.; Layden, T.J.; Krahmer, R.; Ferguson, J., 1993:
Ursodeoxycholic acid selectively increases hepatic arterial blood flow in parallel with bile flow in the rat

Levenson, D.E.; Bouscarel, B.; Salas, R.; Fromm, H., 1994:
Ursodeoxycholic acid stimulates the translocation of protein kinase C from the cytosol to the membrane of isolated hamster hepatocytes

Khare, S.; Mustafi, R.; Cerda, S.; Yuan, W.; Jagadeeswaran, S.; Dougherty, U.; Tretiakova, M.; Samarel, A.; Cohen, G.; Wang, J.; Moore, C.; Wali, R.; Holgren, C.; Joseph, L.; Fichera, A.; Li, Y.Chun.; Bissonnette, M., 2008:
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein

Ikegami, T.; Matsuzaki, Y.; Shoda, J.; Kano, M.; Asano, T.; Tanaka, N., 1996:
Ursodeoxycholic acid suppresses enhanced expression of group-II phospholipase-A2 on colonic tissue of azoxymethane treated rats

Ghent, C.N.; Cauch Dudek, K.; Heathcote, E.J.; Group, C.P.c Trial, 1997:
Ursodeoxycholic acid therapy effects on pruritus and fatigue in primary biliary cirrhosis

Bateson, M.C.; Gedling, P., 1997:
Ursodeoxycholic acid therapy for primary biliary cirrhosis 10 years population-based experience

Van Thiel, D.H.; Wright, H.I.; Gavaler, J.S., 1992:
Ursodeoxycholic acid therapy for primary sclerosing cholangitis Preliminary report of a randomized controlled trial

Cocjin, J.; Vanderhal, A.; Sehgal, S.; Rosenthal, P., 1993:
Ursodeoxycholic acid therapy for total parenteral nutrition associated cholestasis in the neonate

Wiesner, R.H.; Jorgenson, R.; Perdigoto, R., 1990:
Ursodeoxycholic acid therapy from primary biliary cirrhosis progression of disease despite near normalization of biochemical liver tests

Bateson, M.C., 1990:
Ursodeoxycholic acid therapy in chronic active hepatitis

Combes, B.; Carithers, R.L.Jr; Mcdonald, M.F.; Maddrey, W.C.; Munoz, S.J.; Boyer, J.L.; Zetterman, R.; Peters, M.G.; Luketic, V., 1991:
Ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

Balistreri, W.F.; A Kader, H.H.; Setchell, K.D.R., 1991:
Ursodeoxycholic acid therapy in patients with the alagille syndrome syndromic paucity of intrahepatic bile ducts results of a multicenter pilot trial

Jacquemin, E.; Hermans, D.; Myara, A.; Habes, D.; Debray, D.; Hadchouel, M.; Sokal, E.M.; Bernard, O., 1997:
Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis

Kita, Y.; Beck, Y.; Teraoka, S.; Yokota, K.; Andoh, Y.; Nagao, T.; Gotoh, M.; Sakon, M.; Monden, M., 1996:
Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report

Poupon, R.; Poupon, R.E., 1995:
Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children

Fried, R.H.; Willson, R.A.; Fisher, L.D.; Sullivan, K.M.; Murakami, C.S.; Hinds, M.; Mcdonald, G.B., 1990:
Ursodeoxycholic acid therapy of chronic graft versus host disease of the liver following allogeneic bone marrow transplantation

Schiedermaier, P.; Hansen, S.; Brensing, K.A.; Raab, P.; Sauerbruch, T., 1995:
Ursodeoxycholic acid treatment augments gallbladder volume but does not alter fasting portal blood flow in healthy volunteers

Barbara, L.; Fromm, H.; Morselli Labate, A.M.; Malavolti, M.; Talarico, R.; Sama, C., 1991:
Ursodeoxycholic acid treatment decreases serum apo b cholesterol coupling in man

James, O.F., 1990:
Ursodeoxycholic acid treatment for chronic cholestatic liver disease

Wouters, R.S.; Bos, L.P.; Engels, L.G., 1990:
Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis

Lirussi, F.; Beccarello, A.; Okolicsanyi, L., 1991:
Ursodeoxycholic acid treatment in active cirrhosis with or without hepatitis c virus antibodies

O'brien S.; Fitzgerald, M.X.; Hegarty, J.E., 1992:
Ursodeoxycholic acid treatment in cystic fibrosis related liver disease

Talarico, R.; Malavolti, M.; Morselli Labate, A.M.; Cicognani, C.; Zamboni, L.; Danesi, G.; Mastroianni, A.; Sama, C., 1996:
Ursodeoxycholic acid treatment in patients with alcoholic fatty liver

Szalay, L.; Herszenyi, L.; Karteszi, M.; Gergely, P.; Schaff, Z.; Feher, J., 1990:
Ursodeoxycholic acid treatment in primary biliary cirrhosis

Malavolti, M.; Morselli Labate, A.M.; Sama, C.; Talarico, R.; Venturoli, N.; Barbara, L., 1991:
Ursodeoxycholic acid treatment increases serum hdl total cholesterol ratio in man

O'brien C.; Senior, J.R.; Batta, A.K.; Arora, R.; Tint, G.S.; Salen, G., 1989:
Ursodeoxycholic acid treatment produces marked clinical and biochemical amelioration of primary sclerosing cholangitis

Schaffner, F., 1991:
Ursodeoxycholic acid u plus colchicine c for treatment of primary biliary cirrhosis pcb

Malavolti, M.; Labate, A.M.M.; Sama, C.; Rusticali, A.G.; Talarico, R.; Venturoli, N.; Barbara, L., 1991:
Ursodeoxycholic acid udca administration increases the hdl ldl cholesterol ratio in the hypercholesterolemic man

Lacaille, F.; Paradis, K., 1992:
Ursodeoxycholic acid udca and its conjugates decrease lymphocyte proliferation to mitogenic stimuli

Lacaille, F.; Paradis, K., 1992:
Ursodeoxycholic acid udca and its conjugates decrease lymphocyte proliferation to mitogenic stimuli through different mechanisms

Balistreri, W.F.; A Kader, H.H.; Heubi, J.E.; Setchell, K.D.R.; Whitington, P., 1990:
Ursodeoxycholic acid udca decreases serum cholesterol levels ameliorates symptoms and improves biochemical parameters in pediatric patients with chronic intrahepatic cholestasis

Hillaire, S.; Ballet, F.; Poupon, R., 1992:
Ursodeoxycholic acid udca did not protect human hepatocyte in culture against toxic effect of chenodeoxycholic acid cdca

Friman, S.; Nilsson, B.; Thune, A.; Svanvik, J., 1991:
Ursodeoxycholic acid udca enhances canalicular bile flow in man as measured by biliary clearance of peg 900

Ital Multicent Proj Udca Treat Pbc, 1989:
Ursodeoxycholic acid udca for symptomatic primary biliary cirrhosis pbc a double blind multicenter trial

Poupon, R.E.; Poupon, R.; Udca Pbc Group, 1989:
Ursodeoxycholic acid udca for treatment of primary biliary cirrhosis pbc interim analysis of a double blind multicenter randomized trial

May, G.R.; Shaffer, E.A.; Sutherland, L.R., 1991:
Ursodeoxycholic acid udca has greater efficacy than chenodeoxycholic acid cdca in gallstone dissolution a meta analysis

Jazrawi, R.P.; D.C.estecker J.; Brittain, A.; Goggin, P.M.; Galatola, G.; Joseph, A.E.A.; Maxwell, J.D.; Northfield, T.C., 1991:
Ursodeoxycholic acid udca improves hepatic bile acid transit and excretion in primary biliary cirrhosis pbc

Malavolti, M.; Sama, C.; Labate, A.M.M.; Chianura, A.; Talarico, R.; Rossi, M.; Barbara, L., 1990:
Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis

Malavolti, M.; Sama, C.; Morselli Labata, A.M.; Venturoli, N.; Barbara, L., 1990:
Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis

Lirussi, F.; Beccarello, A.; Okolicsanyi, L., 1991:
Ursodeoxycholic acid udca in active cirrhosis influence of hepatitis c virus hcv infection

Buzzelli, G.; Moscarella, S.; Focardi, G.; Giusti, A.; Gentilini, P., 1991:
Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial

Bellentani, S.; Manenti, F.; Tiribelli, C.; Podda, M., 1991:
Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial

Michael, S.; Simko, V.; Oberstein, E., 1991:
Ursodeoxycholic acid udca in in vitro rat liver slices exposed to hepatotoxic cc14 or acetaminophen acp

Poupon, R.E.; Magot, T.; Verneau, C.; Chretien, Y.; Eschwege, E., 1992:
Ursodeoxycholic acid udca in primary biliary cirrhosis cholesterol lowering properties

Leuschner, U.; Dienes, H.P.; Guldutuna, S.; Birkenfeld, G.; Leuschner, M., 1990:
Ursodeoxycholic acid udca influences immune parameters in patients with primary biliary cirrhosis pbc

Rudolph, G.; Walker, S.; Kloters Planchky, P.; Raedsch, R.; Stiehl, A., 1991:
Ursodeoxycholic acid udca inhibits the active absorption of bile acids ba in the terminal ileum of rat

Bouscarel, B.; Fromm, H., 1991:
Ursodeoxycholic acid udca mobilizes intracellular calcium and activates glycogen phosphorylase in a time dependent fashion in isolated hamster hepatocytes

Tazuma, S.; Sagawa, H.; Sasaki, M.; Yamashita, G.; Aihara, N.; Tao, S.; Hatsushika, S.; Ohya, T.; Horiuchi, I.; Kajiyama, G., 1992:
Ursodeoxycholic acid udca prevents early recurrence of cholesterol gallstone after successful extracorporeal shock wave lithotripsy eswl

Guelduetuna, S.; Imhof, M.; Hoffmann, T.; Zimmer, G.; Leuschner, U., 1990:
Ursodeoxycholic acid udca protects basolateral liver plasma membranes bllpm against toxic bile salts

Poo, J.L.; Feldmann, G.; Erlinger, S.; Braillon, A.; Lebrec, D., 1990:
Ursodeoxycholic acid udca reduces liver histologic alterations and portal hypertension induced by bile duct ligation in the rat

Carubbi, F.; Balli, F.; Bertolani, P.; Bozzoli, M.; Messora, R.; Manenti, A.L.; Guicciardi, M.E.; Carulli, N., 1992:
Ursodeoxycholic acid udca therapy in byler disease patients case reports

Colombo, C.; Setchell, K.D.R.; Podda, M.; Battezzati, P.M.; Crosignani, A.; Assaisso, M.L.; Giunta, A., 1991:
Ursodeoxycholic acid udca therapy in patients with cystic fibrosis cf and liver disease a dose response study

Balistreri, W.F.; Heubi, J.E.; Whitington, P.; Perrault, J.; Bancroft, J.; Setchell, K.D.R., 1989:
Ursodeoxycholic acid udca therapy in pediatric hepatobiliary disease

Cotting, J.; Lentze, M.; Reichen, J., 1989:
Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis

Lirussi, F.; Beccarello, A.; Bortolato, L.; Okolicsanyi, L., 1992:
Ursodeoxycholic acid udca treatment in alcoholic patients influence of hepatitis c virus hcv infection

Lirussi, F.; Rusticali, G.; Iemmolo, R.M.; Okolicsanyi, L., 1990:
Ursodeoxycholic acid udca vs silymarin sily in patients with active cirrhosis

Rudolph, G.; Benz, C.; Sauer, P.; Stremmel, W.; Stiehl, A., 1996:
Ursodeoxycholic acid versus tauroursodeoxycholic acid Crossover study of their absorption and biliary enrichment in man

Mazzella, G.; Cipolla, A.; Villanova, N.; Polimeni, C.; Cerre, C.; Montagnani, M.; Sipahi, A.M.; Parini, P.; Festi, D.; Roda, E., 1994:
Ursodeoxycholic acid, differently from simvastatin, decreases cholesterol secretion in dieting obese subjects

Widauer, J.O., 1996:
Ursodeoxycholic acid-containing medicament in a liquid administration form

Poupon, R.E.; Chretien, Y.; Balkau, B.; Niard, A.M.; Poupon, R., 1992:
Ursodeoxycholic therapy for primary biliary cirrhosis A four year controlled study

Galabert, C.; Lengrand, D.; Montet, J.C.; Dimier, J.T.; Chazalette, J.P., 1991:
Ursodeoxycholic treatment in patients with cystic fibrosis and associated liver disease

Tso, P.; Fukagawa, K.; Lillienau, J.; Hofmann, A.F., 1993:
Ursodeoxycholyl sarcosine inhibits intestinal cholesterol absorption but not triglyceride absorption

Barrioz, T.; Ingrand, P.; Besson, I.; Labat, J.; Beauchant, M., 1994:
Ursodesoxycholic acid combined with norfloxacine prevented polyethylene stent occlusion Result of a randomized study

O'brien, C.B.; Henzel, B.; Shields, D.; Long, W.B.; Wolfe, L.; Yoder, A., 1994:
Ursodiol and IFN-alpha for the treatment of chronic hepatitis C

O'brien, C.B.; Brass, C.A.; Long, W.B.; Rubin, R.A.; Kincaid, M.C.; Henzel, B., 1993:
Ursodiol and interferon alfa-2B for the treatment of chronic hepatitis C

Arora, R.; Batta, A.K.; Salen, G.; O'brien C.; Senior, J.R., 1990:
Ursodiol changes biliary bile acid composition and conjugation in patients with primary biliary cirrhosis

Brugge, W.R.; Che, W.Y.; Malet, P.F., 1993:
Ursodiol reduces chronic symptoms of cholelithiasis

Brugge, W.R.; Shiffman, M.L.; Furth, E.L.; Macdermott, R.P.; Malet, P.F., 1993:
Ursodiol reduces gallbladder bile mucin and immunoglobulins in gallstone patients

Lacerda, M.A.; Lindor, K.D.; Jorgensen, R.A.; Rossi, S.; Hofmann, A.; Dickson, E.R., 1993:
Ursodiol therapy in primary biliary cirrhosis Enrichment correlates with biochemical improvement

Senior, J.R.; O'brien C.B.; Wiesner, R.H., 1990:
Ursodiol therapy of primary sclerosing cholangitis reduces the predicted mortality risk

O'brien C.B.; Senior, J.R.; Sternlieb, J.M.; Sample, M.; Saul, S.M.; Arora, R.; Batta, A.K.; Salen, G., 1990:
Ursodiol treatment of primary biliary cirrhosis

Galzigna, L.; Ross, R.; Setchell, K.D.R.; Tauschel, H.D.; Brunetti, G.; D.P.dova, C., 1997:
Ursofalk suspension A bioequivalence study vs ursofalk capsules investigating UDCA serum levels, biliary enrichment and tolerability in healthy volunteers

Ying Q L.; Simon, S.R., 1991:
Ursolic acid and its triterpenoid analogs are natural slowly binding inhibitors of plasmin

Mamedova, M.E.; Aslanov, S.M., 1992:
Ursolic acid content in Olea europaea L flowers from Azerbaijan

Popova, O.I.; Murav'ev D.A., 1990:
Ursolic acid from the leaf bearing shoots of viscum album

Agarwal, D.P.; Visen, P.K.S.; Saraswat, B., 1998:
Ursolic acid protects against alcohol-induced toxicity in rat hepatocytes